doc_id,sentence,text_marked,e1_text,e1_type,e1_start,e1_end,e2_text,e2_type,e2_start,e2_end,relation,source
polg_18502641_spans.jsonl::line375,"Discussion We found two novel heterozygous POLG1 mutations in a compound heterozygous patient characterized by PEO,","Discussion We found two novel heterozygous [E1]POLG1[/E1] mutations in a compound heterozygous patient characterized by [E2]PEO[/E2],",POLG1,GENE,483,488,PEO,HPO_TERM,551,554,HasRelation,gold
polg_18581472_spans.jsonl::line436,W748S) mutation in POLG1,W748S) mutation in [E1]POLG1[/E1][E2][/E2],POLG1,GENE,304,309,focal epilepsy,HPO_TERM,390,404,HasRelation,gold
polg_18581472_spans.jsonl::line436,W748S) mutation in POLG1,W748S) mutation in [E1]POLG1[/E1][E2][/E2],POLG1,GENE,304,309,myoclonus,HPO_TERM,406,415,HasRelation,gold
polg_18581472_spans.jsonl::line436,W748S) mutation in POLG1,W748S) mutation in [E1]POLG1[/E1][E2][/E2],POLG1,GENE,304,309,ataxia,HPO_TERM,420,426,HasRelation,gold
polg_18581472_spans.jsonl::line436,W748S) mutation in POLG1,W748S) mutation in [E1]POLG1[/E1][E2][/E2],POLG1,GENE,304,309,facial dyskinesia,HPO_TERM,519,536,HasRelation,gold
polg_18581472_spans.jsonl::line438,We present a case with the typical clinical features of POLG1 mutation and additional novel ﬁndings of palatal tremor with HOD on MRI and facial dyskinesia,We present a case with the typical clinical features of [E1]POLG1[/E1] mutation and additional novel ﬁndings of [E2]palatal tremor[/E2] with HOD on MRI and facial dyskinesia,POLG1,GENE,56,61,palatal tremor,HPO_TERM,103,117,HasRelation,gold
polg_18581472_spans.jsonl::line438,We present a case with the typical clinical features of POLG1 mutation and additional novel ﬁndings of palatal tremor with HOD on MRI and facial dyskinesia,We present a case with the typical clinical features of [E1]POLG1[/E1] mutation and additional novel ﬁndings of palatal tremor with HOD on MRI and [E2]facial dyskinesia[/E2],POLG1,GENE,56,61,facial dyskinesia,HPO_TERM,138,155,HasRelation,gold
polg_18783964_spans.jsonl::line0,"Seizure 18 (2009) 232–234 Case report Proof of progression over time: Finally fulminant brain, muscle, and liver affection in Alpers syndrome associated with the A467T POLG1 mutation M","Seizure 18 (2009) 232–234 Case report Proof of progression over time: Finally fulminant brain, muscle, and liver affection in [E2]Alpers syndrome[/E2] associated with the [E1]A467[/E1]T POLG1 mutation M",A467,GENE_VARIANT,162,166,Alpers syndrome,HPO_TERM,126,141,HasRelation,gold
polg_18783964_spans.jsonl::line0,"Seizure 18 (2009) 232–234 Case report Proof of progression over time: Finally fulminant brain, muscle, and liver affection in Alpers syndrome associated with the A467T POLG1 mutation M","Seizure 18 (2009) 232–234 Case report Proof of progression over time: Finally fulminant brain, muscle, and liver affection in [E2]Alpers syndrome[/E2] associated with the A467T [E1]POLG1[/E1] mutation M",POLG1,GENE,168,173,Alpers syndrome,HPO_TERM,126,141,HasRelation,gold
polg_19195941_spans.jsonl::line10,"Here, we describe the case of an 18-month-old patient with recurrent hypoketotic hypoglycaemia and fatal liver dysfunction with tissue-specific mtDNA depletion due to mutations in the POLG1 gene","Here, we describe the case of an 18-month-old patient with [E2]recurrent hypoketotic hypoglycaemia[/E2] and fatal liver dysfunction with tissue-specific mtDNA depletion due to mutations in the [E1]POLG1[/E1] gene",POLG1,GENE,184,189,recurrent hypoketotic hypoglycaemia,HPO_TERM,59,94,HasRelation,gold
polg_19195941_spans.jsonl::line10,"Here, we describe the case of an 18-month-old patient with recurrent hypoketotic hypoglycaemia and fatal liver dysfunction with tissue-specific mtDNA depletion due to mutations in the POLG1 gene","Here, we describe the case of an 18-month-old patient with recurrent hypoketotic hypoglycaemia and [E2]fatal liver dysfunction[/E2] with tissue-specific mtDNA depletion due to mutations in the [E1]POLG1[/E1] gene",POLG1,GENE,184,189,fatal liver dysfunction,HPO_TERM,99,122,HasRelation,gold
polg_19195941_spans.jsonl::line10,"Here, we describe the case of an 18-month-old patient with recurrent hypoketotic hypoglycaemia and fatal liver dysfunction with tissue-specific mtDNA depletion due to mutations in the POLG1 gene","Here, we describe the case of an 18-month-old patient with recurrent hypoketotic hypoglycaemia and fatal liver dysfunction with tissue-specific [E2]mtDNA depletion[/E2] due to mutations in the [E1]POLG1[/E1] gene",POLG1,GENE,184,189,mtDNA depletion,HPO_TERM,144,159,HasRelation,gold
polg_19538466_spans.jsonl::line8,"In this study, we describe the morphological, cyto-immunocytochemical, biochemical and molecular genetic results in a 16-months old child, who died of liver failure due to mutations in the polymerase 'Y (POLG) gene","In this study, we describe the morphological, cyto-immunocytochemical, biochemical and molecular genetic results in a 16-months old child, who died [E2]of liver failure[/E2] due to mutations in the [E1]polymerase 'Y[/E1] (POLG) gene",polymerase 'Y,GENE,189,202,of liver failure,HPO_TERM,148,164,HasRelation,gold
polg_19538466_spans.jsonl::line8,"In this study, we describe the morphological, cyto-immunocytochemical, biochemical and molecular genetic results in a 16-months old child, who died of liver failure due to mutations in the polymerase 'Y (POLG) gene","In this study, we describe the morphological, cyto-immunocytochemical, biochemical and molecular genetic results in a 16-months old child, who died [E2]of liver failure[/E2] due to mutations in the polymerase 'Y ([E1]POLG[/E1]) gene",POLG,GENE,204,208,of liver failure,HPO_TERM,148,164,HasRelation,gold
polg_20385918_spans.jsonl::line0,"Golomb, MD, MSc Objective: To describe a child with apparent brain biopsy–confirmed acute disseminated encephalomyelitis (ADEM) but genetic confirmation of compound heterozygosity for DNA mutations of the polymerase 'Y (POLG) gene","Golomb, MD, MSc Objective: To describe a child with apparent brain biopsy–confirmed [E2]acute disseminated encephalomyelitis[/E2] (ADEM) but genetic confirmation of compound heterozygosity for DNA mutations of the [E1]polymerase 'Y[/E1] (POLG) gene",polymerase 'Y,GENE,308,321,acute disseminated encephalomyelitis,HPO_TERM,187,223,HasRelation,gold
polg_20385918_spans.jsonl::line0,"Golomb, MD, MSc Objective: To describe a child with apparent brain biopsy–confirmed acute disseminated encephalomyelitis (ADEM) but genetic confirmation of compound heterozygosity for DNA mutations of the polymerase 'Y (POLG) gene","Golomb, MD, MSc Objective: To describe a child with apparent brain biopsy–confirmed acute disseminated encephalomyelitis ([E2]ADEM[/E2]) but genetic confirmation of compound heterozygosity for DNA mutations of the [E1]polymerase 'Y[/E1] (POLG) gene",polymerase 'Y,GENE,308,321,ADEM,HPO_TERM,225,229,HasRelation,gold
polg_20385918_spans.jsonl::line0,"Golomb, MD, MSc Objective: To describe a child with apparent brain biopsy–confirmed acute disseminated encephalomyelitis (ADEM) but genetic confirmation of compound heterozygosity for DNA mutations of the polymerase 'Y (POLG) gene","Golomb, MD, MSc Objective: To describe a child with apparent brain biopsy–confirmed [E2]acute disseminated encephalomyelitis[/E2] (ADEM) but genetic confirmation of compound heterozygosity for DNA mutations of the polymerase 'Y ([E1]POLG[/E1]) gene",POLG,GENE,323,327,acute disseminated encephalomyelitis,HPO_TERM,187,223,HasRelation,gold
polg_20385918_spans.jsonl::line0,"Golomb, MD, MSc Objective: To describe a child with apparent brain biopsy–confirmed acute disseminated encephalomyelitis (ADEM) but genetic confirmation of compound heterozygosity for DNA mutations of the polymerase 'Y (POLG) gene","Golomb, MD, MSc Objective: To describe a child with apparent brain biopsy–confirmed acute disseminated encephalomyelitis ([E2]ADEM[/E2]) but genetic confirmation of compound heterozygosity for DNA mutations of the polymerase 'Y ([E1]POLG[/E1]) gene",POLG,GENE,323,327,ADEM,HPO_TERM,225,229,HasRelation,gold
polg_20385918_spans.jsonl::line17,"elination, suggesting a wider phenotypic spectrum associated with POLG mutations.","[E2]elination[/E2], suggesting a wider phenotypic spectrum associated with [E1]POLG[/E1] mutations.",POLG,GENE,66,70,elination,HPO_TERM,0,9,HasRelation,gold
polg_20434700_spans.jsonl::line0,Compound Heterozygous Polymerase Gamma Gene Mutation in a Patient With Alpers Disease Javier F,Compound Heterozygous [E1]Polymerase Gamma[/E1] Gene Mutation in a Patient With [E2]Alpers Disease[/E2] Javier F,Polymerase Gamma,GENE,22,38,Alpers Disease,HPO_TERM,71,85,HasRelation,gold
polg_20513108_spans.jsonl::line8,We report a sporadic case of an 80-year-old compound heterozygote man who presented with SANDO and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ p.P587L/p.G848S),We report a sporadic case of an 80-year-old compound[E2] heterozygote man who pre[/E2]sented with SANDO and was found to have three known pathogenic mutations in the [E1]POLG1[/E1] gene (p.T251I/ p.P587L/p.G848S),POLG1,GENE,602,607,sensory ataxic neuropathy,HPO_TERM,303,328,HasRelation,gold
polg_20513108_spans.jsonl::line8,We report a sporadic case of an 80-year-old compound heterozygote man who presented with SANDO and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ p.P587L/p.G848S),We report a sporadic case of an 80-year-old compound heterozygote man who prese[E2]nted with [/E2]SANDO and was found to have three known pathogenic mutations in the [E1]POLG1[/E1] gene (p.T251I/ p.P587L/p.G848S),POLG1,GENE,602,607,dysarthria,HPO_TERM,330,340,HasRelation,gold
polg_20513108_spans.jsonl::line8,We report a sporadic case of an 80-year-old compound heterozygote man who presented with SANDO and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ p.P587L/p.G848S),We report a sporadic case of an 80-year-old compound heterozygote man who presented with SANDO [E2]and was found to[/E2] have three known pathogenic mutations in the [E1]POLG1[/E1] gene (p.T251I/ p.P587L/p.G848S),POLG1,GENE,602,607,ophthalmoparesis,HPO_TERM,346,362,HasRelation,gold
polg_20513108_spans.jsonl::line8,We report a sporadic case of an 80-year-old compound heterozygote man who presented with SANDO and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ p.P587L/p.G848S),We report a sporadic case of an 80-year-old compound heterozygote man who presented with [E2]SANDO[/E2] and was found to have three known pathogenic mutations in the [E1]POLG1[/E1] gene (p.T251I/ p.P587L/p.G848S),POLG1,GENE,602,607,SANDO,HPO_TERM,534,539,HasRelation,gold
polg_20513108_spans.jsonl::line8,We report a sporadic case of an 80-year-old compound heterozygote man who presented with SANDO and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ p.P587L/p.G848S),We report a sporadic case of an 80-year-old compound[E2] heterozygote man who pre[/E2]sented with SANDO and was found to have three known pathogenic mutations in the POLG1 gene ([E1]p.T251I/[/E1] p.P587L/p.G848S),p.T251I/,GENE_VARIANT,614,622,sensory ataxic neuropathy,HPO_TERM,303,328,HasRelation,gold
polg_20513108_spans.jsonl::line8,We report a sporadic case of an 80-year-old compound heterozygote man who presented with SANDO and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ p.P587L/p.G848S),We report a sporadic case of an 80-year-old compound heterozygote man who prese[E2]nted with [/E2]SANDO and was found to have three known pathogenic mutations in the POLG1 gene ([E1]p.T251I/[/E1] p.P587L/p.G848S),p.T251I/,GENE_VARIANT,614,622,dysarthria,HPO_TERM,330,340,HasRelation,gold
polg_20513108_spans.jsonl::line8,We report a sporadic case of an 80-year-old compound heterozygote man who presented with SANDO and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ p.P587L/p.G848S),We report a sporadic case of an 80-year-old compound heterozygote man who presented with SANDO [E2]and was found to[/E2] have three known pathogenic mutations in the POLG1 gene ([E1]p.T251I/[/E1] p.P587L/p.G848S),p.T251I/,GENE_VARIANT,614,622,ophthalmoparesis,HPO_TERM,346,362,HasRelation,gold
polg_20513108_spans.jsonl::line8,We report a sporadic case of an 80-year-old compound heterozygote man who presented with SANDO and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ p.P587L/p.G848S),We report a sporadic case of an 80-year-old compound heterozygote man who presented with [E2]SANDO[/E2] and was found to have three known pathogenic mutations in the POLG1 gene ([E1]p.T251I/[/E1] p.P587L/p.G848S),p.T251I/,GENE_VARIANT,614,622,SANDO,HPO_TERM,534,539,HasRelation,gold
polg_20513108_spans.jsonl::line8,We report a sporadic case of an 80-year-old compound heterozygote man who presented with SANDO and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ p.P587L/p.G848S),We report a sporadic case of an 80-year-old compound[E2] heterozygote man who pre[/E2]sented with SANDO and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ [E1]p.P587L[/E1]/p.G848S),p.P587L,GENE_VARIANT,623,630,sensory ataxic neuropathy,HPO_TERM,303,328,HasRelation,gold
polg_20513108_spans.jsonl::line8,We report a sporadic case of an 80-year-old compound heterozygote man who presented with SANDO and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ p.P587L/p.G848S),We report a sporadic case of an 80-year-old compound heterozygote man who prese[E2]nted with [/E2]SANDO and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ [E1]p.P587L[/E1]/p.G848S),p.P587L,GENE_VARIANT,623,630,dysarthria,HPO_TERM,330,340,HasRelation,gold
polg_20513108_spans.jsonl::line8,We report a sporadic case of an 80-year-old compound heterozygote man who presented with SANDO and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ p.P587L/p.G848S),We report a sporadic case of an 80-year-old compound heterozygote man who presented with SANDO [E2]and was found to[/E2] have three known pathogenic mutations in the POLG1 gene (p.T251I/ [E1]p.P587L[/E1]/p.G848S),p.P587L,GENE_VARIANT,623,630,ophthalmoparesis,HPO_TERM,346,362,HasRelation,gold
polg_20513108_spans.jsonl::line8,We report a sporadic case of an 80-year-old compound heterozygote man who presented with SANDO and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ p.P587L/p.G848S),We report a sporadic case of an 80-year-old compound heterozygote man who presented with [E2]SANDO[/E2] and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ [E1]p.P587L[/E1]/p.G848S),p.P587L,GENE_VARIANT,623,630,SANDO,HPO_TERM,534,539,HasRelation,gold
polg_20513108_spans.jsonl::line8,We report a sporadic case of an 80-year-old compound heterozygote man who presented with SANDO and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ p.P587L/p.G848S),We report a sporadic case of an 80-year-old compound[E2] heterozygote man who pre[/E2]sented with SANDO and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ p.P587L/[E1]p.G848S[/E1]),p.G848S,GENE_VARIANT,631,638,sensory ataxic neuropathy,HPO_TERM,303,328,HasRelation,gold
polg_20513108_spans.jsonl::line8,We report a sporadic case of an 80-year-old compound heterozygote man who presented with SANDO and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ p.P587L/p.G848S),We report a sporadic case of an 80-year-old compound heterozygote man who prese[E2]nted with [/E2]SANDO and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ p.P587L/[E1]p.G848S[/E1]),p.G848S,GENE_VARIANT,631,638,dysarthria,HPO_TERM,330,340,HasRelation,gold
polg_20513108_spans.jsonl::line8,We report a sporadic case of an 80-year-old compound heterozygote man who presented with SANDO and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ p.P587L/p.G848S),We report a sporadic case of an 80-year-old compound heterozygote man who presented with SANDO [E2]and was found to[/E2] have three known pathogenic mutations in the POLG1 gene (p.T251I/ p.P587L/[E1]p.G848S[/E1]),p.G848S,GENE_VARIANT,631,638,ophthalmoparesis,HPO_TERM,346,362,HasRelation,gold
polg_20513108_spans.jsonl::line8,We report a sporadic case of an 80-year-old compound heterozygote man who presented with SANDO and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ p.P587L/p.G848S),We report a sporadic case of an 80-year-old compound heterozygote man who presented with [E2]SANDO[/E2] and was found to have three known pathogenic mutations in the POLG1 gene (p.T251I/ p.P587L/[E1]p.G848S[/E1]),p.G848S,GENE_VARIANT,631,638,SANDO,HPO_TERM,534,539,HasRelation,gold
polg_20513108_spans.jsonl::line11,Only a few cases of SANDO associated with POLG1 mutations have been reported.3–8 We report a case of SANDO associated with known pathogenic POLG1 mutations that presented in late life in a compound heterozygote male.,Only a few cases of SANDO associated with POLG1 mutations have been reported.3–8 We report a case of [E2]SANDO[/E2] associated with known pathogenic [E1]POLG1[/E1] mutations that presented in late life in a compound heterozygote male.,POLG1,GENE,765,770,SANDO,HPO_TERM,726,731,HasRelation,gold
polg_20708716_spans.jsonl::line2,"Using oligonucleotide array CGH, we identiﬁed a compound heterozygous large intragenic deletion encompassing exons 15–21 of this gene in a child with Alpers syndrome due to mtDNA depletion","Using oligonucleotide array CGH, we identiﬁed a compound heterozygous large intragenic [E1]deletion encompassing exons 15–21[/E1] of this gene in a child with [E2]Alpers syndrome[/E2] due to mtDNA depletion",deletion encompassing exons 15–21,GENE_VARIANT,447,480,Alpers syndrome,HPO_TERM,510,525,HasRelation,gold
polg_20708716_spans.jsonl::line2,"Using oligonucleotide array CGH, we identiﬁed a compound heterozygous large intragenic deletion encompassing exons 15–21 of this gene in a child with Alpers syndrome due to mtDNA depletion","Using oligonucleotide array CGH, we identiﬁed a compound heterozygous large intragenic [E1]deletion encompassing exons 15–21[/E1] of this gene in a child with Alpers syndrome due to [E2]mtDNA depletion[/E2]",deletion encompassing exons 15–21,GENE_VARIANT,447,480,mtDNA depletion,HPO_TERM,533,548,HasRelation,gold
polg_20708716_spans.jsonl::line2,This is the ﬁrst large POLG,[E2]Th[/E2]is is the ﬁrst large [E1]POLG[/E1],POLG,GENE,573,577,Alpers syndrome,HPO_TERM,510,525,HasRelation,gold
polg_20708716_spans.jsonl::line2,This is the ﬁrst large POLG,This is th[E2]e ﬁrst large PO[/E2][E1]POLG[/E1],POLG,GENE,573,577,mtDNA depletion,HPO_TERM,533,548,HasRelation,gold
polg_20708716_spans.jsonl::line6,"Here we describe a patient with a common POLG disease presentation, Alpers syndrome (MIM# 203700), characterized by early age of onset, fatal intractable seizures, hepatic failure and global neurological deterioration (Naviaux and Nguyen, 2004)","Here we describe a patient with a common [E1]POLG[/E1] disease presentation, [E2]Alpers syndrome[/E2] (MIM# 203700), characterized by early age of onset, fatal intractable seizures, hepatic failure and global neurological deterioration (Naviaux and Nguyen, 2004)",POLG,GENE,41,45,Alpers syndrome,HPO_TERM,68,83,HasRelation,gold
polg_20708716_spans.jsonl::line6,"Here we describe a patient with a common POLG disease presentation, Alpers syndrome (MIM# 203700), characterized by early age of onset, fatal intractable seizures, hepatic failure and global neurological deterioration (Naviaux and Nguyen, 2004)","Here we describe a patient with a common [E1]POLG[/E1] disease presentation, Alpers syndrome (MIM# 203700), characterized by [E2]early age of onset[/E2], fatal intractable seizures, hepatic failure and global neurological deterioration (Naviaux and Nguyen, 2004)",POLG,GENE,41,45,early age of onset,HPO_TERM,116,134,HasRelation,gold
polg_20708716_spans.jsonl::line6,"Here we describe a patient with a common POLG disease presentation, Alpers syndrome (MIM# 203700), characterized by early age of onset, fatal intractable seizures, hepatic failure and global neurological deterioration (Naviaux and Nguyen, 2004)","Here we describe a patient with a common [E1]POLG[/E1] disease presentation, Alpers syndrome (MIM# 203700), characterized by early age of onset, [E2]fatal[/E2] intractable seizures, hepatic failure and global neurological deterioration (Naviaux and Nguyen, 2004)",POLG,GENE,41,45,fatal,HPO_TERM,136,141,HasRelation,gold
polg_20708716_spans.jsonl::line6,"Here we describe a patient with a common POLG disease presentation, Alpers syndrome (MIM# 203700), characterized by early age of onset, fatal intractable seizures, hepatic failure and global neurological deterioration (Naviaux and Nguyen, 2004)","Here we describe a patient with a common [E1]POLG[/E1] disease presentation, Alpers syndrome (MIM# 203700), characterized by early age of onset, fatal [E2]intractable seizures[/E2], hepatic failure and global neurological deterioration (Naviaux and Nguyen, 2004)",POLG,GENE,41,45,intractable seizures,HPO_TERM,142,162,HasRelation,gold
polg_20708716_spans.jsonl::line6,"Here we describe a patient with a common POLG disease presentation, Alpers syndrome (MIM# 203700), characterized by early age of onset, fatal intractable seizures, hepatic failure and global neurological deterioration (Naviaux and Nguyen, 2004)","Here we describe a patient with a common [E1]POLG[/E1] disease presentation, Alpers syndrome (MIM# 203700), characterized by early age of onset, fatal intractable seizures, [E2]hepatic failure[/E2] and global neurological deterioration (Naviaux and Nguyen, 2004)",POLG,GENE,41,45,hepatic failure,HPO_TERM,164,179,HasRelation,gold
polg_20708716_spans.jsonl::line6,"Here we describe a patient with a common POLG disease presentation, Alpers syndrome (MIM# 203700), characterized by early age of onset, fatal intractable seizures, hepatic failure and global neurological deterioration (Naviaux and Nguyen, 2004)","Here we describe a patient with a common [E1]POLG[/E1] disease presentation, Alpers syndrome (MIM# 203700), characterized by early age of onset, fatal intractable seizures, hepatic failure and [E2]global neurological deterioration[/E2] (Naviaux and Nguyen, 2004)",POLG,GENE,41,45,global neurological deterioration,HPO_TERM,184,217,HasRelation,gold
polg_21259344_spans.jsonl::line2,"Here, for the ﬁrst time, we describe a patient who presented with clinical and radiological ﬁndings suggestive of multiple system atrophy (MSA) of the cerebellar subtype (MSA-C), but was shown to have mutations of POLG1","Here, for the ﬁrst time, we describe a patient who presented with clinical and radiological ﬁndings suggestive of [E2]multiple system atrophy[/E2] (MSA) of the cerebellar subtype (MSA-C), but was shown to have mutations of [E1]POLG1[/E1]",POLG1,GENE,214,219,multiple system atrophy,HPO_TERM,114,137,HasRelation,gold
polg_21515089_spans.jsonl::line0,"Epilepsy & Behavior 21 (2011) 206–210 Case Report Parieto-occipital lobe epilepsy caused by a POLG1 compound heterozygous A467T/W748S genotype David Roshal, David Glosser, Andro Zangaladze ⁎ Department of Neurology, Thomas Jefferson University Hospital, Philadelphia, PA, USA a r t i c l e i n f o Article history: Received 22 December 2010 Revised 3 March 2011 Accepted 4 March 2011 Available online 22 April 2011 Keywords: POLG1 gene mutation Mithochondrial disorder A467T/W748S genotype Somatosensory seizures Status Epilepticus a b s t r a c t","Epilepsy & Behavior 21 (2011) 206–210 Case Report [E2]Parieto-occipital lobe epilepsy[/E2] caused by a [E1]POLG1[/E1] compound heterozygous A467T/W748S genotype David Roshal, David Glosser, Andro Zangaladze ⁎ Department of Neurology, Thomas Jefferson University Hospital, Philadelphia, PA, USA a r t i c l e i n f o Article history: Received 22 December 2010 Revised 3 March 2011 Accepted 4 March 2011 Available online 22 April 2011 Keywords: POLG1 gene mutation Mithochondrial disorder A467T/W748S genotype Somatosensory seizures Status Epilepticus a b s t r a c t",POLG1,GENE,94,99,Parieto-occipital lobe epilepsy,HPO_TERM,50,81,HasRelation,gold
polg_21515089_spans.jsonl::line0,"Epilepsy & Behavior 21 (2011) 206–210 Case Report Parieto-occipital lobe epilepsy caused by a POLG1 compound heterozygous A467T/W748S genotype David Roshal, David Glosser, Andro Zangaladze ⁎ Department of Neurology, Thomas Jefferson University Hospital, Philadelphia, PA, USA a r t i c l e i n f o Article history: Received 22 December 2010 Revised 3 March 2011 Accepted 4 March 2011 Available online 22 April 2011 Keywords: POLG1 gene mutation Mithochondrial disorder A467T/W748S genotype Somatosensory seizures Status Epilepticus a b s t r a c t","Epilepsy & Behavior 21 (2011) 206–210 Case Report [E2]Parieto-occipital lobe epilepsy[/E2] caused by a POLG1 compound heterozygous [E1]A467T[/E1]/W748S genotype David Roshal, David Glosser, Andro Zangaladze ⁎ Department of Neurology, Thomas Jefferson University Hospital, Philadelphia, PA, USA a r t i c l e i n f o Article history: Received 22 December 2010 Revised 3 March 2011 Accepted 4 March 2011 Available online 22 April 2011 Keywords: POLG1 gene mutation Mithochondrial disorder A467T/W748S genotype Somatosensory seizures Status Epilepticus a b s t r a c t",A467T,GENE_VARIANT,122,127,Parieto-occipital lobe epilepsy,HPO_TERM,50,81,HasRelation,gold
polg_21515089_spans.jsonl::line0,"Epilepsy & Behavior 21 (2011) 206–210 Case Report Parieto-occipital lobe epilepsy caused by a POLG1 compound heterozygous A467T/W748S genotype David Roshal, David Glosser, Andro Zangaladze ⁎ Department of Neurology, Thomas Jefferson University Hospital, Philadelphia, PA, USA a r t i c l e i n f o Article history: Received 22 December 2010 Revised 3 March 2011 Accepted 4 March 2011 Available online 22 April 2011 Keywords: POLG1 gene mutation Mithochondrial disorder A467T/W748S genotype Somatosensory seizures Status Epilepticus a b s t r a c t","Epilepsy & Behavior 21 (2011) 206–210 Case Report [E2]Parieto-occipital lobe epilepsy[/E2] caused by a POLG1 compound heterozygous A467T/[E1]W748S[/E1] genotype David Roshal, David Glosser, Andro Zangaladze ⁎ Department of Neurology, Thomas Jefferson University Hospital, Philadelphia, PA, USA a r t i c l e i n f o Article history: Received 22 December 2010 Revised 3 March 2011 Accepted 4 March 2011 Available online 22 April 2011 Keywords: POLG1 gene mutation Mithochondrial disorder A467T/W748S genotype Somatosensory seizures Status Epilepticus a b s t r a c t",W748S,GENE_VARIANT,128,133,Parieto-occipital lobe epilepsy,HPO_TERM,50,81,HasRelation,gold
polg_22357363_spans.jsonl::line8,"We present a case study showing spinal cord, peripheral nerve and selective nuclear degeneration in the brain due to recessive compound heterozygous mutations of POLG1","We present a case study showing spinal cord, peripheral nerve and selective nuclear [E2]degeneration in the brain[/E2] due to recessive compound heterozygous mutations of [E1]POLG1[/E1]",POLG1,GENE,162,167,degeneration in the brain,HPO_TERM,84,109,HasRelation,gold
polg_22357363_spans.jsonl::line8,"We present a case study showing spinal cord, peripheral nerve and selective nuclear degeneration in the brain due to recessive compound heterozygous mutations of POLG1","We present a case study showing spinal cord, peripheral nerve and selective nuclear degeneration in the brain due to recessive compound heterozygous mutations of [E1]POLG1[/E1][E2][/E2]",POLG1,GENE,162,167,cerebellar features,HPO_TERM,265,284,HasRelation,gold
polg_22357363_spans.jsonl::line8,"We present a case study showing spinal cord, peripheral nerve and selective nuclear degeneration in the brain due to recessive compound heterozygous mutations of POLG1","We present a case study showing spinal cord, peripheral nerve and selective nuclear degeneration in the brain due to recessive compound heterozygous mutations of [E1]POLG1[/E1][E2][/E2]",POLG1,GENE,162,167,ataxia,HPO_TERM,290,296,HasRelation,gold
polg_22357363_spans.jsonl::line8,"We present a case study showing spinal cord, peripheral nerve and selective nuclear degeneration in the brain due to recessive compound heterozygous mutations of POLG1","We present a case study showing spinal cord, peripheral nerve and selective nuclear degeneration in the brain due to recessive compound heterozygous mutations of [E1]POLG1[/E1][E2][/E2]",POLG1,GENE,162,167,neuropathy,HPO_TERM,322,332,HasRelation,gold
polg_22357363_spans.jsonl::line8,"We present a case study showing spinal cord, peripheral nerve and selective nuclear degeneration in the brain due to recessive compound heterozygous mutations of POLG1","We present a case study showing spinal cord, peripheral nerve and selective nuclear degeneration in the brain due to recessive compound heterozygous mutations of [E1]POLG1[/E1][E2][/E2]",POLG1,GENE,162,167,depressed and absent reﬂexes in all limbs,HPO_TERM,338,379,HasRelation,gold
polg_22357363_spans.jsonl::line8,"We present a case study showing spinal cord, peripheral nerve and selective nuclear degeneration in the brain due to recessive compound heterozygous mutations of POLG1","We present a case study showing spinal cord, peripheral nerve and selective nuclear degeneration in the brain due to recessive compound heterozygous mutations of [E1]POLG1[/E1][E2][/E2]",POLG1,GENE,162,167,distal weakness,HPO_TERM,381,396,HasRelation,gold
polg_22357363_spans.jsonl::line8,"We present a case study showing spinal cord, peripheral nerve and selective nuclear degeneration in the brain due to recessive compound heterozygous mutations of POLG1","We present a case study showing spinal cord, peripheral nerve and selective nuclear degeneration in the brain due to recessive compound heterozygous mutations of [E1]POLG1[/E1][E2][/E2]",POLG1,GENE,162,167,distal sensory loss of proprioception and vibration,HPO_TERM,401,452,HasRelation,gold
polg_22357363_spans.jsonl::line29,Autopsy conﬁrmed that the patient had multiple mtDNA deletions associated with compound heterozygous POLG mutations (p.A862T and p.H277L) in skeletal muscle,Autopsy conﬁrmed that the patient had [E2]multiple mtDNA deletions[/E2] associated with compound heterozygous [E1]POLG[/E1] mutations (p.A862T and p.H277L) in skeletal muscle,POLG,GENE,101,105,multiple mtDNA deletions,HPO_TERM,38,62,HasRelation,gold
polg_22357363_spans.jsonl::line29,Autopsy conﬁrmed that the patient had multiple mtDNA deletions associated with compound heterozygous POLG mutations (p.A862T and p.H277L) in skeletal muscle,Autopsy conﬁrmed that the patient had [E2]multiple mtDNA deletions[/E2] associated with compound heterozygous POLG mutations ([E1]p.A862T[/E1] and p.H277L) in skeletal muscle,p.A862T,GENE_VARIANT,117,124,multiple mtDNA deletions,HPO_TERM,38,62,HasRelation,gold
polg_22357363_spans.jsonl::line29,Autopsy conﬁrmed that the patient had multiple mtDNA deletions associated with compound heterozygous POLG mutations (p.A862T and p.H277L) in skeletal muscle,Autopsy conﬁrmed that the patient had [E2]multiple mtDNA deletions[/E2] associated with compound heterozygous POLG mutations (p.A862T and [E1]p.H277L[/E1]) in skeletal muscle,p.H277L,GENE_VARIANT,129,136,multiple mtDNA deletions,HPO_TERM,38,62,HasRelation,gold
polg_22805437_spans.jsonl::line1,We present a patient with a new mutation in spacer region of mitochondrial polymerase gamma protein (P765T),We present a patient with a new mutation in spacer region of mitochondrial [E1]polymerase gamma protein[/E1] (P765T)[E2][/E2],polymerase gamma protein,GENE,284,308,sensory–ataxic neuropathy,HPO_TERM,375,400,HasRelation,gold
polg_22805437_spans.jsonl::line1,We present a patient with a new mutation in spacer region of mitochondrial polymerase gamma protein (P765T),We present a patient with a new mutation in spacer region of mitochondrial [E1]polymerase gamma protein[/E1] (P765T)[E2][/E2],polymerase gamma protein,GENE,284,308,ophthalmoplegia,HPO_TERM,402,417,HasRelation,gold
polg_22805437_spans.jsonl::line1,We present a patient with a new mutation in spacer region of mitochondrial polymerase gamma protein (P765T),We present a patient with a new mutation in spacer region of mitochondrial [E1]polymerase gamma protein[/E1] (P765T)[E2][/E2],polymerase gamma protein,GENE,284,308,dysarthria,HPO_TERM,419,429,HasRelation,gold
polg_22805437_spans.jsonl::line1,We present a patient with a new mutation in spacer region of mitochondrial polymerase gamma protein (P765T),We present a patient with a new mutation in spacer region of mitochondrial [E1]polymerase gamma protein[/E1] (P765T)[E2][/E2],polymerase gamma protein,GENE,284,308,gastroparesis,HPO_TERM,434,447,HasRelation,gold
polg_22805437_spans.jsonl::line1,We present a patient with a new mutation in spacer region of mitochondrial polymerase gamma protein (P765T),We present a patient with a new mutation in spacer region of mitochondrial polymerase gamma protein ([E1]P765T[/E1])[E2][/E2],P765T,GENE_VARIANT,310,315,sensory–ataxic neuropathy,HPO_TERM,375,400,HasRelation,gold
polg_22805437_spans.jsonl::line1,We present a patient with a new mutation in spacer region of mitochondrial polymerase gamma protein (P765T),We present a patient with a new mutation in spacer region of mitochondrial polymerase gamma protein ([E1]P765T[/E1])[E2][/E2],P765T,GENE_VARIANT,310,315,ophthalmoplegia,HPO_TERM,402,417,HasRelation,gold
polg_22805437_spans.jsonl::line1,We present a patient with a new mutation in spacer region of mitochondrial polymerase gamma protein (P765T),We present a patient with a new mutation in spacer region of mitochondrial polymerase gamma protein ([E1]P765T[/E1])[E2][/E2],P765T,GENE_VARIANT,310,315,dysarthria,HPO_TERM,419,429,HasRelation,gold
polg_22805437_spans.jsonl::line1,We present a patient with a new mutation in spacer region of mitochondrial polymerase gamma protein (P765T),We present a patient with a new mutation in spacer region of mitochondrial polymerase gamma protein ([E1]P765T[/E1])[E2][/E2],P765T,GENE_VARIANT,310,315,gastroparesis,HPO_TERM,434,447,HasRelation,gold
polg_22931735_spans.jsonl::line0,Case Report/Case Series Early-onset Ataxia With Progressive External Ophthalmoplegia Associated With POLG Mutation Autosomal Recessive Mitochondrial Ataxic Syndrome or SANDO,Case Report/Case Series Early-onset [E2]Ataxia[/E2] With Progressive External Ophthalmoplegia Associated With [E1]POLG[/E1] Mutation Autosomal Recessive Mitochondrial Ataxic Syndrome or SANDO,POLG,GENE,101,105,Ataxia,HPO_TERM,36,42,HasRelation,gold
polg_22931735_spans.jsonl::line0,Case Report/Case Series Early-onset Ataxia With Progressive External Ophthalmoplegia Associated With POLG Mutation Autosomal Recessive Mitochondrial Ataxic Syndrome or SANDO,Case Report/Case Series Early-onset Ataxia With [E2]Progressive External Ophthalmoplegia[/E2] Associated With [E1]POLG[/E1] Mutation Autosomal Recessive Mitochondrial Ataxic Syndrome or SANDO,POLG,GENE,101,105,Progressive External Ophthalmoplegia,HPO_TERM,48,84,HasRelation,gold
polg_22931735_spans.jsonl::line1,"To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia","To illustrate this, we present a case of [E2]progressive ataxia[/E2] caused by [E1]A467T[/E1] and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia",A467T,GENE_VARIANT,678,683,progressive ataxia,HPO_TERM,649,667,HasRelation,gold
polg_22931735_spans.jsonl::line1,"To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia","To illustrate this, we present a case of progressive ataxia caused by [E1]A467T[/E1] and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as [E2]choreoathetotic[/E2] movements and dysphonia",A467T,GENE_VARIANT,678,683,choreoathetotic,HPO_TERM,833,848,HasRelation,gold
polg_22931735_spans.jsonl::line1,"To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia","To illustrate this, we present a case of progressive ataxia caused by [E1]A467T[/E1] and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and [E2]dysphonia[/E2]",A467T,GENE_VARIANT,678,683,dysphonia,HPO_TERM,863,872,HasRelation,gold
polg_22931735_spans.jsonl::line1,"To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia","To illustrate this, we present a case of progressive ataxia caused by [E1]A467T[/E1] and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia[E2][/E2]",A467T,GENE_VARIANT,678,683,hyperintensities in the thalamus,HPO_TERM,951,983,HasRelation,gold
polg_22931735_spans.jsonl::line1,"To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia","To illustrate this, we present a case of progressive ataxia caused by [E1]A467T[/E1] and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia[E2][/E2]",A467T,GENE_VARIANT,678,683,inferior olives,HPO_TERM,985,1000,HasRelation,gold
polg_22931735_spans.jsonl::line1,"To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia","To illustrate this, we present a case of progressive ataxia caused by [E1]A467T[/E1] and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia[E2][/E2]",A467T,GENE_VARIANT,678,683,cerebellum,HPO_TERM,1006,1016,HasRelation,gold
polg_22931735_spans.jsonl::line1,"To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia","To illustrate this, we present a case of [E2]progressive ataxia[/E2] caused by A467T and [E1]W748S[/E1] mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia",W748S,GENE_VARIANT,688,693,progressive ataxia,HPO_TERM,649,667,HasRelation,gold
polg_22931735_spans.jsonl::line1,"To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia","To illustrate this, we present a case of progressive ataxia caused by A467T and [E1]W748S[/E1] mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as [E2]choreoathetotic[/E2] movements and dysphonia",W748S,GENE_VARIANT,688,693,choreoathetotic,HPO_TERM,833,848,HasRelation,gold
polg_22931735_spans.jsonl::line1,"To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia","To illustrate this, we present a case of progressive ataxia caused by A467T and [E1]W748S[/E1] mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and [E2]dysphonia[/E2]",W748S,GENE_VARIANT,688,693,dysphonia,HPO_TERM,863,872,HasRelation,gold
polg_22931735_spans.jsonl::line1,"To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia","To illustrate this, we present a case of progressive ataxia caused by A467T and [E1]W748S[/E1] mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia[E2][/E2]",W748S,GENE_VARIANT,688,693,hyperintensities in the thalamus,HPO_TERM,951,983,HasRelation,gold
polg_22931735_spans.jsonl::line1,"To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia","To illustrate this, we present a case of progressive ataxia caused by A467T and [E1]W748S[/E1] mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia[E2][/E2]",W748S,GENE_VARIANT,688,693,inferior olives,HPO_TERM,985,1000,HasRelation,gold
polg_22931735_spans.jsonl::line1,"To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia","To illustrate this, we present a case of progressive ataxia caused by A467T and [E1]W748S[/E1] mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia[E2][/E2]",W748S,GENE_VARIANT,688,693,cerebellum,HPO_TERM,1006,1016,HasRelation,gold
polg_22931735_spans.jsonl::line1,"To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia","To illustrate this, we present a case of [E2]progressive ataxia[/E2] caused by A467T and W748S mutations of [E1]POLG[/E1] gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia",POLG,GENE,707,711,progressive ataxia,HPO_TERM,649,667,HasRelation,gold
polg_22931735_spans.jsonl::line1,"To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia","To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of [E1]POLG[/E1] gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as [E2]choreoathetotic[/E2] movements and dysphonia",POLG,GENE,707,711,choreoathetotic,HPO_TERM,833,848,HasRelation,gold
polg_22931735_spans.jsonl::line1,"To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia","To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of [E1]POLG[/E1] gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and [E2]dysphonia[/E2]",POLG,GENE,707,711,dysphonia,HPO_TERM,863,872,HasRelation,gold
polg_22931735_spans.jsonl::line1,"To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia","To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of [E1]POLG[/E1] gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia[E2][/E2]",POLG,GENE,707,711,hyperintensities in the thalamus,HPO_TERM,951,983,HasRelation,gold
polg_22931735_spans.jsonl::line1,"To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia","To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of [E1]POLG[/E1] gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia[E2][/E2]",POLG,GENE,707,711,inferior olives,HPO_TERM,985,1000,HasRelation,gold
polg_22931735_spans.jsonl::line1,"To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of POLG gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia","To illustrate this, we present a case of progressive ataxia caused by A467T and W748S mutations of [E1]POLG[/E1] gene, who presented with overlapping symptoms of autosomal recessive mitochondrial ataxic syndrome and SANDO, as well as choreoathetotic movements and dysphonia[E2][/E2]",POLG,GENE,707,711,cerebellum,HPO_TERM,1006,1016,HasRelation,gold
polg_25466440_spans.jsonl::line0,"Brain & Development 37 (2015) 719–724 Case Report www.elsevier.com/locate/braindev Myocerebrohepatopathy spectrum disorder due to POLG mutations: A clinicopathological report Hesham Montassir a,b, Yoshihiro Maegaki a,⇑, Kei Murayama c, Taro Yamazaki d, Masakazu Kohda e, Akira Ohtake d, Hiroyasu Iwasa e, Yukiko Yatsuka f, Yasushi Okazaki e,f, Chitose Sugiura a, Ikuo Nagata g, Mitsuo Toyoshima h, Yoshiaki Saito a, Masayuki Itoh i, Ichizo Nishino j, Kousaku Ohno a a Division of Child Neurology, Faculty of Medicine, Tottori University, Yonago, Japan","Brain & Development 37 (2015) 719–724 Case Report www.elsevier.com/locate/braindev [E2]Myocerebrohepatopathy[/E2] spectrum disorder due to [E1]POLG[/E1] mutations: A clinicopathological report Hesham Montassir a,b, Yoshihiro Maegaki a,⇑, Kei Murayama c, Taro Yamazaki d, Masakazu Kohda e, Akira Ohtake d, Hiroyasu Iwasa e, Yukiko Yatsuka f, Yasushi Okazaki e,f, Chitose Sugiura a, Ikuo Nagata g, Mitsuo Toyoshima h, Yoshiaki Saito a, Masayuki Itoh i, Ichizo Nishino j, Kousaku Ohno a a Division of Child Neurology, Faculty of Medicine, Tottori University, Yonago, Japan",POLG,GENE,130,134,Myocerebrohepatopathy,HPO_TERM,83,104,HasRelation,gold
polg_25466440_spans.jsonl::line3,"We report on the clinical, neuropathological, and genetic ﬁndings of a Japanese case with myocerebrohepatopathy spectrum (MCHS) disorder due to polymerase gamma (POLG) mutations","We report on the clinical, neuropathological, and genetic ﬁndings of a Japanese case with [E2]myocerebrohepatopathy[/E2] spectrum (MCHS) disorder due to [E1]polymerase gamma[/E1] (POLG) mutations",polymerase gamma,GENE,144,160,myocerebrohepatopathy,HPO_TERM,90,111,HasRelation,gold
polg_25466440_spans.jsonl::line3,"We report on the clinical, neuropathological, and genetic ﬁndings of a Japanese case with myocerebrohepatopathy spectrum (MCHS) disorder due to polymerase gamma (POLG) mutations","We report on the clinical, neuropathological, and genetic ﬁndings of a Japanese case with myocerebrohepatopathy spectrum (MCHS) disorder due to [E1]polymerase gamma[/E1] (POLG) mutations[E2][/E2]",polymerase gamma,GENE,144,160,poor sucking,HPO_TERM,197,209,HasRelation,gold
polg_25466440_spans.jsonl::line3,"We report on the clinical, neuropathological, and genetic ﬁndings of a Japanese case with myocerebrohepatopathy spectrum (MCHS) disorder due to polymerase gamma (POLG) mutations","We report on the clinical, neuropathological, and genetic ﬁndings of a Japanese case with myocerebrohepatopathy spectrum (MCHS) disorder due to [E1]polymerase gamma[/E1] (POLG) mutations[E2][/E2]",polymerase gamma,GENE,144,160,failure to thrive,HPO_TERM,214,231,HasRelation,gold
polg_25466440_spans.jsonl::line3,"We report on the clinical, neuropathological, and genetic ﬁndings of a Japanese case with myocerebrohepatopathy spectrum (MCHS) disorder due to polymerase gamma (POLG) mutations","We report on the clinical, neuropathological, and genetic ﬁndings of a Japanese case with myocerebrohepatopathy spectrum (MCHS) disorder due to [E1]polymerase gamma[/E1] (POLG) mutations[E2][/E2]",polymerase gamma,GENE,144,160,frequent vomiting,HPO_TERM,262,279,HasRelation,gold
polg_25466440_spans.jsonl::line3,"We report on the clinical, neuropathological, and genetic ﬁndings of a Japanese case with myocerebrohepatopathy spectrum (MCHS) disorder due to polymerase gamma (POLG) mutations","We report on the clinical, neuropathological, and genetic ﬁndings of a Japanese case with myocerebrohepatopathy spectrum (MCHS) disorder due to [E1]polymerase gamma[/E1] (POLG) mutations[E2][/E2]",polymerase gamma,GENE,144,160,developmental regression,HPO_TERM,284,308,HasRelation,gold
polg_25466440_spans.jsonl::line3,"We report on the clinical, neuropathological, and genetic ﬁndings of a Japanese case with myocerebrohepatopathy spectrum (MCHS) disorder due to polymerase gamma (POLG) mutations","We report on the clinical, neuropathological, and genetic ﬁndings of a Japanese case with [E2]myocerebrohepatopathy[/E2] spectrum (MCHS) disorder due to polymerase gamma ([E1]POLG[/E1]) mutations",POLG,GENE,162,166,myocerebrohepatopathy,HPO_TERM,90,111,HasRelation,gold
polg_25466440_spans.jsonl::line3,"We report on the clinical, neuropathological, and genetic ﬁndings of a Japanese case with myocerebrohepatopathy spectrum (MCHS) disorder due to polymerase gamma (POLG) mutations","We report on the clinical, neuropathological, and genetic ﬁndings of a Japanese case with myocerebrohepatopathy spectrum (MCHS) disorder due to polymerase gamma ([E1]POLG[/E1]) mutations[E2][/E2]",POLG,GENE,162,166,poor sucking,HPO_TERM,197,209,HasRelation,gold
polg_25466440_spans.jsonl::line3,"We report on the clinical, neuropathological, and genetic ﬁndings of a Japanese case with myocerebrohepatopathy spectrum (MCHS) disorder due to polymerase gamma (POLG) mutations","We report on the clinical, neuropathological, and genetic ﬁndings of a Japanese case with myocerebrohepatopathy spectrum (MCHS) disorder due to polymerase gamma ([E1]POLG[/E1]) mutations[E2][/E2]",POLG,GENE,162,166,failure to thrive,HPO_TERM,214,231,HasRelation,gold
polg_25466440_spans.jsonl::line3,"We report on the clinical, neuropathological, and genetic ﬁndings of a Japanese case with myocerebrohepatopathy spectrum (MCHS) disorder due to polymerase gamma (POLG) mutations","We report on the clinical, neuropathological, and genetic ﬁndings of a Japanese case with myocerebrohepatopathy spectrum (MCHS) disorder due to polymerase gamma ([E1]POLG[/E1]) mutations[E2][/E2]",POLG,GENE,162,166,frequent vomiting,HPO_TERM,262,279,HasRelation,gold
polg_25466440_spans.jsonl::line3,"We report on the clinical, neuropathological, and genetic ﬁndings of a Japanese case with myocerebrohepatopathy spectrum (MCHS) disorder due to polymerase gamma (POLG) mutations","We report on the clinical, neuropathological, and genetic ﬁndings of a Japanese case with myocerebrohepatopathy spectrum (MCHS) disorder due to polymerase gamma ([E1]POLG[/E1]) mutations[E2][/E2]",POLG,GENE,162,166,developmental regression,HPO_TERM,284,308,HasRelation,gold
polg_25724872_spans.jsonl::line5,behavioural and cognitive abnormalities associated with a novel mutation in the POLG1 gene,[E2]behavioural[/E2] and cognitive abnormalities associated with a novel mutation in the [E1]POLG1[/E1] gene,POLG1,GENE,431,436,behavioural,HPO_TERM,351,362,HasRelation,gold
polg_25724872_spans.jsonl::line5,behavioural and cognitive abnormalities associated with a novel mutation in the POLG1 gene,behavioural and [E2]cognitive abnormalities[/E2] associated with a novel mutation in the [E1]POLG1[/E1] gene,POLG1,GENE,431,436,cognitive abnormalities,HPO_TERM,367,390,HasRelation,gold
polg_25724872_spans.jsonl::line11,"We report on a case of parkinsonism, PEO, ptosis, and behavioural and cognitive abnormalities associated with a novel mutation in the POLG1 gene","We report on a case of [E2]parkinsonism[/E2], PEO, ptosis, and behavioural and cognitive abnormalities associated with a novel mutation in the [E1]POLG1[/E1] gene",POLG1,GENE,134,139,parkinsonism,HPO_TERM,23,35,HasRelation,gold
polg_25724872_spans.jsonl::line11,"We report on a case of parkinsonism, PEO, ptosis, and behavioural and cognitive abnormalities associated with a novel mutation in the POLG1 gene","We report on a case of parkinsonism, [E2]PEO[/E2], ptosis, and behavioural and cognitive abnormalities associated with a novel mutation in the [E1]POLG1[/E1] gene",POLG1,GENE,134,139,PEO,HPO_TERM,37,40,HasRelation,gold
polg_25724872_spans.jsonl::line11,"We report on a case of parkinsonism, PEO, ptosis, and behavioural and cognitive abnormalities associated with a novel mutation in the POLG1 gene","We report on a case of parkinsonism, PEO, [E2]ptosis[/E2], and behavioural and cognitive abnormalities associated with a novel mutation in the [E1]POLG1[/E1] gene",POLG1,GENE,134,139,ptosis,HPO_TERM,42,48,HasRelation,gold
polg_25724872_spans.jsonl::line11,"We report on a case of parkinsonism, PEO, ptosis, and behavioural and cognitive abnormalities associated with a novel mutation in the POLG1 gene","We report on a case of parkinsonism, PEO, ptosis, and [E2]behavioural and cognitive abnormalities[/E2] associated with a novel mutation in the [E1]POLG1[/E1] gene",POLG1,GENE,134,139,behavioural and cognitive abnormalities,HPO_TERM,54,93,HasRelation,gold
polg_25724872_spans.jsonl::line21,"Conclusion We report on a novel mutation in the POLG1 gene which leads to an amino acid change, p.His945Leu, associated with parkinsonism accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, cognitive disturbances, obsessive disorder, PEO and ptosis","Conclusion We report on a novel mutation in the [E1]POLG1[/E1] gene which leads to an amino acid change, p.His945Leu, associated with [E2]parkinsonism[/E2] accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, cognitive disturbances, obsessive disorder, PEO and ptosis",POLG1,GENE,48,53,parkinsonism,HPO_TERM,125,137,HasRelation,gold
polg_25724872_spans.jsonl::line21,"Conclusion We report on a novel mutation in the POLG1 gene which leads to an amino acid change, p.His945Leu, associated with parkinsonism accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, cognitive disturbances, obsessive disorder, PEO and ptosis","Conclusion We report on a novel mutation in the [E1]POLG1[/E1] gene which leads to an amino acid change, p.His945Leu, associated with parkinsonism accompanied [E2]by a nigro-striatal dopaminergic deﬁcit[/E2] and response to levodopa, cognitive disturbances, obsessive disorder, PEO and ptosis",POLG1,GENE,48,53,by a nigro-striatal dopaminergic deﬁcit,HPO_TERM,150,189,HasRelation,gold
polg_25724872_spans.jsonl::line21,"Conclusion We report on a novel mutation in the POLG1 gene which leads to an amino acid change, p.His945Leu, associated with parkinsonism accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, cognitive disturbances, obsessive disorder, PEO and ptosis","Conclusion We report on a novel mutation in the [E1]POLG1[/E1] gene which leads to an amino acid change, p.His945Leu, associated with parkinsonism accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, [E2]cognitive disturbances[/E2], obsessive disorder, PEO and ptosis",POLG1,GENE,48,53,cognitive disturbances,HPO_TERM,216,238,HasRelation,gold
polg_25724872_spans.jsonl::line21,"Conclusion We report on a novel mutation in the POLG1 gene which leads to an amino acid change, p.His945Leu, associated with parkinsonism accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, cognitive disturbances, obsessive disorder, PEO and ptosis","Conclusion We report on a novel mutation in the [E1]POLG1[/E1] gene which leads to an amino acid change, p.His945Leu, associated with parkinsonism accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, cognitive disturbances, [E2]obsessive disorder[/E2], PEO and ptosis",POLG1,GENE,48,53,obsessive disorder,HPO_TERM,240,258,HasRelation,gold
polg_25724872_spans.jsonl::line21,"Conclusion We report on a novel mutation in the POLG1 gene which leads to an amino acid change, p.His945Leu, associated with parkinsonism accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, cognitive disturbances, obsessive disorder, PEO and ptosis","Conclusion We report on a novel mutation in the [E1]POLG1[/E1] gene which leads to an amino acid change, p.His945Leu, associated with parkinsonism accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, cognitive disturbances, obsessive disorder, [E2]PEO[/E2] and ptosis",POLG1,GENE,48,53,PEO,HPO_TERM,260,263,HasRelation,gold
polg_25724872_spans.jsonl::line21,"Conclusion We report on a novel mutation in the POLG1 gene which leads to an amino acid change, p.His945Leu, associated with parkinsonism accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, cognitive disturbances, obsessive disorder, PEO and ptosis","Conclusion We report on a novel mutation in the [E1]POLG1[/E1] gene which leads to an amino acid change, p.His945Leu, associated with parkinsonism accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, cognitive disturbances, obsessive disorder, PEO and [E2]ptosis[/E2]",POLG1,GENE,48,53,ptosis,HPO_TERM,268,274,HasRelation,gold
polg_25724872_spans.jsonl::line21,"Conclusion We report on a novel mutation in the POLG1 gene which leads to an amino acid change, p.His945Leu, associated with parkinsonism accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, cognitive disturbances, obsessive disorder, PEO and ptosis","Conclusion We report on a novel mutation in the POLG1 gene which leads to an amino acid change, [E1]p.His945Leu[/E1], associated with [E2]parkinsonism[/E2] accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, cognitive disturbances, obsessive disorder, PEO and ptosis",p.His945Leu,GENE_VARIANT,96,107,parkinsonism,HPO_TERM,125,137,HasRelation,gold
polg_25724872_spans.jsonl::line21,"Conclusion We report on a novel mutation in the POLG1 gene which leads to an amino acid change, p.His945Leu, associated with parkinsonism accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, cognitive disturbances, obsessive disorder, PEO and ptosis","Conclusion We report on a novel mutation in the POLG1 gene which leads to an amino acid change, [E1]p.His945Leu[/E1], associated with parkinsonism accompanied [E2]by a nigro-striatal dopaminergic deﬁcit[/E2] and response to levodopa, cognitive disturbances, obsessive disorder, PEO and ptosis",p.His945Leu,GENE_VARIANT,96,107,by a nigro-striatal dopaminergic deﬁcit,HPO_TERM,150,189,HasRelation,gold
polg_25724872_spans.jsonl::line21,"Conclusion We report on a novel mutation in the POLG1 gene which leads to an amino acid change, p.His945Leu, associated with parkinsonism accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, cognitive disturbances, obsessive disorder, PEO and ptosis","Conclusion We report on a novel mutation in the POLG1 gene which leads to an amino acid change, [E1]p.His945Leu[/E1], associated with parkinsonism accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, [E2]cognitive disturbances[/E2], obsessive disorder, PEO and ptosis",p.His945Leu,GENE_VARIANT,96,107,cognitive disturbances,HPO_TERM,216,238,HasRelation,gold
polg_25724872_spans.jsonl::line21,"Conclusion We report on a novel mutation in the POLG1 gene which leads to an amino acid change, p.His945Leu, associated with parkinsonism accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, cognitive disturbances, obsessive disorder, PEO and ptosis","Conclusion We report on a novel mutation in the POLG1 gene which leads to an amino acid change, [E1]p.His945Leu[/E1], associated with parkinsonism accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, cognitive disturbances, [E2]obsessive disorder[/E2], PEO and ptosis",p.His945Leu,GENE_VARIANT,96,107,obsessive disorder,HPO_TERM,240,258,HasRelation,gold
polg_25724872_spans.jsonl::line21,"Conclusion We report on a novel mutation in the POLG1 gene which leads to an amino acid change, p.His945Leu, associated with parkinsonism accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, cognitive disturbances, obsessive disorder, PEO and ptosis","Conclusion We report on a novel mutation in the POLG1 gene which leads to an amino acid change, [E1]p.His945Leu[/E1], associated with parkinsonism accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, cognitive disturbances, obsessive disorder, [E2]PEO[/E2] and ptosis",p.His945Leu,GENE_VARIANT,96,107,PEO,HPO_TERM,260,263,HasRelation,gold
polg_25724872_spans.jsonl::line21,"Conclusion We report on a novel mutation in the POLG1 gene which leads to an amino acid change, p.His945Leu, associated with parkinsonism accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, cognitive disturbances, obsessive disorder, PEO and ptosis","Conclusion We report on a novel mutation in the POLG1 gene which leads to an amino acid change, [E1]p.His945Leu[/E1], associated with parkinsonism accompanied by a nigro-striatal dopaminergic deﬁcit and response to levodopa, cognitive disturbances, obsessive disorder, PEO and [E2]ptosis[/E2]",p.His945Leu,GENE_VARIANT,96,107,ptosis,HPO_TERM,268,274,HasRelation,gold
polg_19766516_full.jsonl::line2,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of p.A467T/p.G848S and with a lethal outcome,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of [E1]p.A467T[/E1]/p.G848S and with a lethal outcome[E2][/E2],p.A467T,GENE,78,85,elevated,HPO_TERM,155,163,NoRelation,gold
polg_21515089_spans.jsonl::line1,"We describe a 16-year-old woman with a rare POLG1 A467T/W748S genotype, with a wide range of neurological manifestations, including focal parieto-occipital lobe seizures, migraine headaches, cerebellar ataxia, sensory– motor axonal neuropathy, and impairment of visual perception and cognitive function","We describe a 16-year-old woman with a rare POLG1 A467T/[E1]W748S[/E1] genotype, with a wide range of neurological manifestations, including focal parieto-occipital lobe seizures, migraine headaches, cerebellar ataxia, [E2]sensory– motor axonal neuropathy[/E2], and impairment of visual perception and cognitive function",W748S,GENE_VARIANT,56,61,sensory– motor axonal neuropathy,HPO_TERM,210,242,NoRelation,gold
polg_23430898_spans.jsonl::line1,"We present a case where an entire POLG1 allele is deleted, with a known pathogenic mutation (W748S) on the remaining allele","We present a case where an entire POLG1 allele is deleted, with a known pathogenic mutation ([E1]W748S[/E1]) on the remaining allele[E2][/E2]",W748S,GENE_VARIANT,689,694,with Alpers syndrome,HPO_TERM,753,773,NoRelation,gold
polg_21515089_spans.jsonl::line1,Treatment of epilepsy in patients with a POLG1 compound heterozygous A467T/W748S genotype is very challenging,Treatment of epilepsy in patients with a POLG1 compou[E2]nd heterozygous A467T/W748S gen[/E2][E1]W748S[/E1] genotype is very challenging,W748S,GENE_VARIANT,379,384,impairment of visual perception,HPO_TERM,248,279,NoRelation,gold
polg_25286830_spans.jsonl::line2,"Because of suspected mitochondrial depletion disorder, testing was performed for mitochondrial abnormalities including analysis of the POLG gene, which revealed two pathogenic mutations, c.1399G>A (p.A467T) and c.3285C>G (p.S1095R)","Because of suspected mitochondrial depletion disorder, testing was performed for mitochondrial abnormalities including analysis of the POLG gene, which revealed two pathogenic mutations, c.1399G>A (p.A467T) and c.3285C>G ([E1]p.S1095R[/E1])[E2][/E2]",p.S1095R,GENE,1039,1047,myocerebrohepatopathy,HPO_TERM,1175,1196,NoRelation,gold
polg_24471704_spans.jsonl::line19,One patient aﬀected by POLG1 mutation had three previous episodes of AC before the fatal last one,One patient aﬀected by [E1]POLG1[/E1] mutation had three previous episodes [E2]of AC[/E2] before the fatal last one,POLG1,GENE,242,247,of AC,HPO_TERM,285,290,NoRelation,gold
polg_20803213_spans.jsonl::line9,Urgent DNA analysis indeed revealed a homozygous (A467T) mutation of the POLG1-gene confirming the diagnosis of juvenileonset Alpers’ syndrome.,Urgent DNA analysis indeed revealed a homozygous (A467T) m[E2]utation of the POLG1-gene [/E2][E1]POLG1[/E1]-gene confirming the diagnosis of juvenileonset Alpers’ syndrome.,POLG1,GENE,782,787,cortical occipital lesions,HPO_TERM,624,650,NoRelation,gold
polg_23430898_spans.jsonl::line1,"We present a case where an entire POLG1 allele is deleted, with a known pathogenic mutation (W748S) on the remaining allele","We present a case where an entire [E1]POLG1[/E1] allele is deleted, with a known pathogenic mutation (W748S) on the remaining allele[E2][/E2]",POLG1,GENE,630,635,seizures,HPO_TERM,870,878,NoRelation,gold
polg_25286830_spans.jsonl::line2,"Because of suspected mitochondrial depletion disorder, testing was performed for mitochondrial abnormalities including analysis of the POLG gene, which revealed two pathogenic mutations, c.1399G>A (p.A467T) and c.3285C>G (p.S1095R)","Because of suspected mitochondrial depletion disorder, testing was performed for mitochondrial abnormalities including analysis of the POLG gene, which revealed two pathogenic mutations, c.1399G>A (p.A467T) and c.3285C>G ([E1]p.S1095R[/E1])[E2][/E2]",p.S1095R,GENE,1039,1047,mild atrophy,HPO_TERM,1254,1266,NoRelation,gold
polg_21515089_spans.jsonl::line4,"We describe here a patient with a rare POLG1 A467T/W748S compound heterozygous genotype with a wide range of neurological and nonneurological manifestations, including focal seizures, migraine ⁎ Corresponding author at: 900 Walnut Street, Suite 200, Philadelphia, PA 19107, USA","We describe here a patient with a rare [E1]POLG1[/E1] A467T/W748S compound heterozygous genotype with a wide range of neurological and nonneurological manifestations, including focal seizures, [E2]migraine[/E2] ⁎ Corresponding author at: 900 Walnut Street, Suite 200, Philadelphia, PA 19107, USA",POLG1,GENE,39,44,migraine,HPO_TERM,184,192,NoRelation,gold
polg_20803213_full.jsonl::line9,Urgent DNA analysis indeed revealed a homozygous (A467T) mutation of the POLG1-gene confirming the diagnosis of juvenileonset Alpers’ syndrome.,Urgent DNA analysis indeed revealed a homozygous (A467T) mutation of the POLG1-gene confirming the d[E2]iagnosis of juvenileonset Alpers’ syndrom[/E2][E1]A467[/E1]T) mutation of the POLG1-gene confirming the diagnosis of juvenileonset Alpers’ syndrome.,A467,GENE_VARIANT,759,763,leftsided pulvinar thalamic abnormalities,HPO_TERM,666,707,NoRelation,gold
polg_23248042_spans.jsonl::line1,Mitochondrial disorder was clinically suspected and a homozygous c.2243G>C mutation (p.Trp748Ser) was discovered in the POLG1 gene,Mitochondrial disorder was cl[E2]inicall[/E2]y suspected and a homozygous c.2243G>C mutation (p.Trp748Ser) was discovered in the [E1]POLG1[/E1] gene,POLG1,GENE,817,822,aphasia,HPO_TERM,596,603,NoRelation,gold
polg_23430898_spans.jsonl::line8,The deletion comprises the entire POLG1 gene and the adjacent FANCI gene (OMIM#611360),The deletion co[E2]mprises the ent[/E2][E1]deletion comprises the entire POLG1 gene[/E1] and the adjacent FANCI gene (OMIM#611360),deletion comprises the entire POLG1 gene,GENE_VARIANT,164,204,Alpers syndrome,HPO_TERM,89,104,NoRelation,gold
polg_20803213_spans.jsonl::line14,"One week after admission, DNA analysis revealed a homozygous A467T mutation of the POLG1-gene, confirming the suspected diagnosis of juvenile-onset Alpers’ syndrome","One week after admission, DNA analysis revealed a homozygous A467T mutation of the POLG1-gene, confirming the suspected diagnosi[E2]s of juv[/E2][E1]A467T[/E1] mutation of the POLG1-gene, confirming the suspected diagnosis of juvenile-onset Alpers’ syndrome",A467T,GENE_VARIANT,673,678,thalamus,HPO_TERM,576,584,NoRelation,gold
polg_30936349_spans.jsonl::line2,Genetic studies showed a compound heterozygosity of known pathogenic mutations in the poLG1 gene (variant t252I/p587 L in cis configuration in allele 1 and variant r807C in allele 2),Genetic studies showed a compound heterozygosity of known pathogenic mutations in the poLG1 gene (variant t252I/p587 L in cis configura[E2]tion in allele [/E2]1 and variant [E1]r807C[/E1] in allele 2),r807C,GENE_VARIANT,211,216,ophthalmoplegia,HPO_TERM,0,15,NoRelation,gold
polg_21515089_spans.jsonl::line1,"We describe a 16-year-old woman with a rare POLG1 A467T/W748S genotype, with a wide range of neurological manifestations, including focal parieto-occipital lobe seizures, migraine headaches, cerebellar ataxia, sensory– motor axonal neuropathy, and impairment of visual perception and cognitive function","We describe a 16-year-old woman with a rare [E1]POLG1[/E1] A467T/W748S genotype, with a wide range of neurological manifestations, including focal parieto-occipital lobe seizures, [E2]migraine headaches[/E2], cerebellar ataxia, sensory– motor axonal neuropathy, and impairment of visual perception and cognitive function",POLG1,GENE,44,49,migraine headaches,HPO_TERM,171,189,NoRelation,gold
polg_22778364_spans.jsonl::line15,Molecular genetic analysis revealed multiple mtDNA deletions in muscle and heterozygous in trans mutations p.998S>L and p.1184D>H in the POLG1 gene,Molecular genetic analysis revealed multiple mtDNA deletions in muscle[E2] and heterozygous i[/E2]n trans mutations p.998S>L and [E1]p.1184D>H[/E1] in the POLG1 gene,p.1184D>H,GENE_VARIANT,368,377,COX-negative fibres,HPO_TERM,171,190,NoRelation,gold
polg_19766516_spans.jsonl::line2,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of p.A467T/p.G848S and with a lethal outcome,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of p.A467T/[E1]p.G848S[/E1] and with a lethal outcome[E2][/E2],p.G848S,GENE,86,93,IL-6,HPO_TERM,179,183,NoRelation,gold
polg_22931735_spans.jsonl::line9,"We report on a patient with POLG mutations presenting with ataxia, ophthalmoparesis, and some additional features, who was diagnosed on the basis of MRI findings","We report on a patient with [E1]POLG[/E1] mutations presenting with ataxia, [E2]ophthalmoparesis[/E2], and some additional features, who was diagnosed on the basis of MRI findings",POLG,GENE,28,32,ophthalmoparesis,HPO_TERM,67,83,NoRelation,gold
polg_25129007_spans.jsonl::line7,"The NGS followed by Sanger sequencing in the patient revealed a previously reported homozygous mutation, c.3286C>T (p.Arg1096Cys) in POLG gene, thus confirming diagnosis of POLG-related hepato-cerebral form of mtDNA depletion syndrome overlapping with AlpersHuttenlocher syndrome","The NGS followed by Sanger sequencing in the patient revealed a previously reported homozygous mutation[E1], c.3286C>T[/E1] (p.Arg1096Cys) in POLG gene, thus confirming diagnosis of POLG-related [E2]hepato-cerebral[/E2] form of mtDNA depletion syndrome overlapping with AlpersHuttenlocher syndrome",", c.3286C>T",GENE_VARIANT,239,250,hepato-cerebral,HPO_TERM,322,337,NoRelation,gold
polg_19766516_spans.jsonl::line2,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of p.A467T/p.G848S and with a lethal outcome,We describe a 3.5-year-old female with Alpers disease with a [E1]POLG[/E1] genotype of p.A467T/p.G848S and with a lethal outcome[E2][/E2],POLG,GENE,61,65,"CSF neopterin,",HPO_TERM,164,178,NoRelation,gold
polg_20434700_spans.jsonl::line7,Mitochondrial analysis revealed a DNA polymerase gamma1 (POLG) heterozygous mutation,Mitochondrial analysis revealed a DNA po[E2]lymerase gamma1 (POLG) heterozygou[/E2][E1]POLG[/E1]) heterozygous mutation,POLG,GENE,244,248,abnormal cristae and vacuolization,HPO_TERM,143,177,NoRelation,gold
polg_22778364_spans.jsonl::line0,"Unusual association of diseases/symptoms Novel POLG1 mutations in a patient with adult-onset progressive external ophthalmoplegia and encephalopathy Mika H Martikainen,1 Reetta Hinttala,2 Kari Majamaa2 1 Department of Neurology, Turku University Hospital, Turku, Finland 2 Department of Neurology, Institute of Clinical Medicine, University of Oulu, Oulu, Finland Correspondence to Kari Majamaa, kari.majamaa@oulu.fi Summary","Unusual association of diseases/symptoms Novel [E1]POLG1[/E1] mutations in a patient with adult-onset progressive external ophthalmoplegia and [E2]encephalopathy[/E2] Mika H Martikainen,1 Reetta Hinttala,2 Kari Majamaa2 1 Department of Neurology, Turku University Hospital, Turku, Finland 2 Department of Neurology, Institute of Clinical Medicine, University of Oulu, Oulu, Finland Correspondence to Kari Majamaa, kari.majamaa@oulu.fi Summary",POLG1,GENE,47,52,encephalopathy,HPO_TERM,134,148,NoRelation,gold
polg_22342071_spans.jsonl::line0,"eur o pea n journal o f p aedi atric n eurolog y 16 (2012) 542 e548 Original article Polymerase gamma deficiency (POLG): Clinical course in a child with a two stage evolution from infantile myocerebrohepatopathy spectrum to an Alpers syndrome and neuropathological findings of Leigh’s encephalopathy Emmanuel Scalais a,*, Baudouin Francois b, Patrick Schlesser c, Rene Stevens c, Christian Nuttin a, Jean-Jacques Martin d, Rudy Van Coster e, Sara Seneca f, Frank Roels g, Gert Van Goethem h,i, Ann Lo¨fgren h, Linda De Meirleir j","eur o pea n journal o f p aedi atric n eurolog y 16 (2012) 542 e548 Original article [E1]Polymerase gamma[/E1] deficiency (POLG): Clinical course in a child with a two stage evolution from infantile [E2]myocerebrohepatopathy[/E2] spectrum to an Alpers syndrome and neuropathological findings of Leigh’s encephalopathy Emmanuel Scalais a,*, Baudouin Francois b, Patrick Schlesser c, Rene Stevens c, Christian Nuttin a, Jean-Jacques Martin d, Rudy Van Coster e, Sara Seneca f, Frank Roels g, Gert Van Goethem h,i, Ann Lo¨fgren h, Linda De Meirleir j",Polymerase gamma,GENE,85,101,myocerebrohepatopathy,HPO_TERM,190,211,NoRelation,gold
polg_30936349_spans.jsonl::line2,Genetic studies showed a compound heterozygosity of known pathogenic mutations in the poLG1 gene (variant t252I/p587 L in cis configuration in allele 1 and variant r807C in allele 2),Genetic studies showed a compound heterozygosity of known pathogenic mutations in the poLG1 gene (variant t252I/p587 L in cis configuration in allele 1 and variant r807[E2]C in allele [/E2][E1]r807C[/E1] in allele 2),r807C,GENE_VARIANT,211,216,parkinsonism,HPO_TERM,33,45,NoRelation,gold
polg_23430898_spans.jsonl::line1,"We present a case where an entire POLG1 allele is deleted, with a known pathogenic mutation (W748S) on the remaining allele","We present a case where an entire [E1]POLG1[/E1] allele is deleted, with a known pathogenic mutation (W748S) on the remaining allele[E2][/E2]",POLG1,GENE,630,635,with Alpers syndrome,HPO_TERM,753,773,NoRelation,gold
polg_20803213_full.jsonl::line14,"One week after admission, DNA analysis revealed a homozygous A467T mutation of the POLG1-gene, confirming the suspected diagnosis of juvenile-onset Alpers’ syndrome","One week after admission, DNA analysis revealed a homozygous A467T mutation o[E2]f the POLG1-gene, confirming the suspected diagno[/E2][E1]A467T[/E1] mutation of the POLG1-gene, confirming the suspected diagnosis of juvenile-onset Alpers’ syndrome",A467T,GENE_VARIANT,673,678,hyperintense lesions of the left occipital cortex,HPO_TERM,525,574,NoRelation,gold
polg_19766516_full.jsonl::line2,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of p.A467T/p.G848S and with a lethal outcome,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of p.A467T/[E1]p.G848S[/E1] and with a lethal outcome[E2][/E2],p.G848S,GENE,86,93,reduced CSF 5-methyltetrahydrofolate,HPO_TERM,198,234,NoRelation,gold
polg_18502641_spans.jsonl::line376,The maternal allele predicts a p.W918R aminoacid sub- stitution in a highly conserved position in the pol cA poly- merase domain (http://dir-apps.niehs.nih.gov/polg/) [8],The maternal allele predicts a p.W918R aminoacid sub- stitution in a h[E2]ighly conserved[/E2][E1]p.W918R[/E1] aminoacid sub- stitution in a highly conserved position in the pol cA poly- merase domain (http://dir-apps.niehs.nih.gov/polg/) [8],p.W918R,GENE_VARIANT,131,138,muscle weakness,HPO_TERM,0,15,NoRelation,gold
polg_21515089_spans.jsonl::line1,"We describe a 16-year-old woman with a rare POLG1 A467T/W748S genotype, with a wide range of neurological manifestations, including focal parieto-occipital lobe seizures, migraine headaches, cerebellar ataxia, sensory– motor axonal neuropathy, and impairment of visual perception and cognitive function","We describe a 16-year-old woman with a rare POLG1 [E1]A467T[/E1]/W748S genotype, with a wide range of neurological manifestations, including [E2]focal parieto-occipital lobe seizures[/E2], migraine headaches, cerebellar ataxia, sensory– motor axonal neuropathy, and impairment of visual perception and cognitive function",A467T,GENE_VARIANT,50,55,focal parieto-occipital lobe seizures,HPO_TERM,132,169,NoRelation,gold
polg_19766516_full.jsonl::line2,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of p.A467T/p.G848S and with a lethal outcome,We describe a 3.5-year-old female with [E2]Alpers disease[/E2] with a [E1]POLG[/E1] genotype of p.A467T/p.G848S and with a lethal outcome,POLG,GENE,61,65,Alpers disease,HPO_TERM,39,53,NoRelation,gold
polg_21956653_spans.jsonl::line55,"Nuclear DNA genetic analysis revealed compound heterozygosity for POLG gene mutation, p.W748S, and pT914P variant","Nuclear DNA genetic analysis revealed compound heterozygosity for POLG gene mutation, [E1]p.W748S[/E1], and pT914P variant[E2][/E2]",p.W748S,GENE_VARIANT,607,614,epilepsia partialis continua,HPO_TERM,686,714,NoRelation,gold
polg_19766516_full.jsonl::line2,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of p.A467T/p.G848S and with a lethal outcome,We describe a 3.5-year-old female with Alpers disease with a [E1]POLG[/E1] genotype of p.A467T/p.G848S and with a lethal outcome[E2][/E2],POLG,GENE,61,65,"CSF neopterin,",HPO_TERM,164,178,NoRelation,gold
polg_22342071_spans.jsonl::line0,"eur o pea n journal o f p aedi atric n eurolog y 16 (2012) 542 e548 Original article Polymerase gamma deficiency (POLG): Clinical course in a child with a two stage evolution from infantile myocerebrohepatopathy spectrum to an Alpers syndrome and neuropathological findings of Leigh’s encephalopathy Emmanuel Scalais a,*, Baudouin Francois b, Patrick Schlesser c, Rene Stevens c, Christian Nuttin a, Jean-Jacques Martin d, Rudy Van Coster e, Sara Seneca f, Frank Roels g, Gert Van Goethem h,i, Ann Lo¨fgren h, Linda De Meirleir j","eur o pea n journal o f p aedi atric n eurolog y 16 (2012) 542 e548 Original article [E1]Polymerase gamma[/E1] deficiency (POLG): Clinical course in a child with a two stage evolution from infantile myocerebrohepatopathy spectrum to an Alpers syndrome and neuropathological findings of [E2]Leigh’s encephalopathy[/E2] Emmanuel Scalais a,*, Baudouin Francois b, Patrick Schlesser c, Rene Stevens c, Christian Nuttin a, Jean-Jacques Martin d, Rudy Van Coster e, Sara Seneca f, Frank Roels g, Gert Van Goethem h,i, Ann Lo¨fgren h, Linda De Meirleir j",Polymerase gamma,GENE,85,101,Leigh’s encephalopathy,HPO_TERM,277,299,NoRelation,gold
polg_23430898_spans.jsonl::line8,"Here, we report the finding of a complete deletion of one POLG1 allele in a patient with Alpers syndrome and acute liver failure induced by treatment with VPA","Here, we report the finding of a complete [E1]deletion[/E1] of one POLG1 allele in a patient with Alpers syndrome and [E2]acute liver failure[/E2] induced by treatment with VPA",deletion,GENE_VARIANT,42,50,acute liver failure,HPO_TERM,109,128,NoRelation,gold
polg_20691285_spans.jsonl::line48,"PTC and partial exon 22 skipping for patient 1, complete exon 22 skipping for patient 2, and the severe AHS phenotype in these patients was a consequence of a single-copy gene dose of the p.A467T or the p.[W748S;E1143G] allele","PTC and partial exon 22 skipping for patient 1, [E1]complete exon 22 skipping[/E1] for patient 2, and the [E2]severe AHS[/E2] phenotype in these patients was a consequence of a single-copy gene dose of the p.A467T or the p.[W748S;E1143G] allele",complete exon 22 skipping,GENE_VARIANT,150,175,severe AHS,HPO_TERM,199,209,NoRelation,gold
polg_24471704_spans.jsonl::line15,"The patient with POLG1 mutation is included in the study, despite the ambiguity of classiﬁcation, because of the potential signiﬁcance for the present report","The patient with [E1]POLG1[/E1] mutation is included in the study, despite the ambiguity of classiﬁcation, because of the potential signiﬁcance for the present report[E2][/E2]",POLG1,GENE,155,160,progressive external ophthalmoplegia,HPO_TERM,382,418,NoRelation,gold
polg_27422324_spans.jsonl::line6,AHS was suspected and mutation analysis of the polymerase gamma gene (POLG) revealed compound heterozygotes mutations A467T/W748S,AHS was susp[E2]ected and mutation analysis of[/E2] the polymerase gamma gene (POLG) revealed compound heterozygotes mutations [E1]A467T[/E1]/W748S,A467T,GENE_VARIANT,850,855,elevated lactate concentration,HPO_TERM,615,645,NoRelation,gold
polg_18502641_spans.jsonl::line361,"Here we report two novel mutations in POLG1 in a compound heterozygous patient with autosomal recessive PEO, followed by pseudo- orthostatic tremor evolving into levodopa-responsive parkinsonism","Here we report two novel mutations in [E1]POLG1[/E1] in a compound heterozygous patient with autosomal recessive [E2]PEO[/E2], followed by pseudo- orthostatic tremor evolving into levodopa-responsive parkinsonism",POLG1,GENE,283,288,PEO,HPO_TERM,349,352,NoRelation,gold
polg_20385918_spans.jsonl::line2,"However, polymerase chain reaction amplification and sequencing revealed 2 heterozygous mutations of the POLG gene, suggesting mitochondrial disease","However, polymerase chain reaction amplification and sequencing revealed 2 heterozygous mutations of [E2]the POLG gene[/E2][E1]POLG[/E1] gene, suggesting mitochondrial disease",POLG,GENE,174,178,demyelination,HPO_TERM,22,35,NoRelation,gold
polg_19766516_spans.jsonl::line2,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of p.A467T/p.G848S and with a lethal outcome,We describe a 3.5-year-old female with Alpers disease with a [E1]POLG[/E1] genotype of p.A467T/p.G848S and with a lethal outcome[E2][/E2],POLG,GENE,61,65,IL-6,HPO_TERM,179,183,NoRelation,gold
polg_22342071_spans.jsonl::line14,predicting p.Ala467Thr substitution (paternal) and c.2542G>A predicting p.Gly848Ser substitution (maternal).,predicting p.Ala467Thr substitution (paternal) and c.2542[E2]G>A predicting p.Gly848Ser substitution (maternal[/E2][E1]predicting p.Ala467Thr[/E1] substitution (paternal) and c.2542G>A predicting p.Gly848Ser substitution (maternal).,predicting p.Ala467Thr,GENE_VARIANT,207,229,signal intensity in the right inferior colliculus,HPO_TERM,156,205,NoRelation,gold
polg_19998270_spans.jsonl::line5,"1B) and ruled out a depression-induced ‘‘pseudo-Parkinsonism.’’ In addition, transcranial sonography (performed by an examiner blind to the history and clinical examination of the patient) revealed a hyperechogenic substantia nigra and a hypoechogenic raphe (Fig 1D), thus resembling the characteristic sonography midbrain ﬁndings of IPD with depression.5 Because of the suggestive phenotype and family history, a genetic analysis of the POLG gene was initiated, revealing a heterozygous Tyr955Cys mutation, which is known to present, interalia, as POLG-P with autosomal dominant inheritance.1","1B) and ruled out a depression-induced ‘‘pseudo-Parkinsonism.’’ In addition, transcranial sonography (performed by an examiner blind to the history and clinical examination of the patient) revealed a hyperechogenic substantia nigra and a hypoechogenic raphe (Fig 1D), thus resembling the characteristic sonography midbrain ﬁndings of IPD with depression.5 Because of the suggestive phenotype and family history, a genetic analysis of the POLG gene was initiated, revealing a heterozygous Tyr955Cys mutati[E2]on, which is known to present, interalia, as POLG-P with a[/E2][E1]POLG[/E1] gene was initiated, revealing a heterozygous Tyr955Cys mutation, which is known to present, interalia, as POLG-P with autosomal dominant inheritance.1",POLG,GENE,569,573,symmetric reduction of nigrostriatal dopamine transporters,HPO_TERM,42,100,NoRelation,gold
polg_19766516_full.jsonl::line2,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of p.A467T/p.G848S and with a lethal outcome,We describe a 3.5-year-old female with Alpers disease with a [E1]POLG[/E1] genotype of p.A467T/p.G848S and with a lethal outcome[E2][/E2],POLG,GENE,61,65,IL-6,HPO_TERM,179,183,NoRelation,gold
polg_21515089_spans.jsonl::line1,"We describe a 16-year-old woman with a rare POLG1 A467T/W748S genotype, with a wide range of neurological manifestations, including focal parieto-occipital lobe seizures, migraine headaches, cerebellar ataxia, sensory– motor axonal neuropathy, and impairment of visual perception and cognitive function","We describe a 16-year-old woman with a rare POLG1 A467T/[E1]W748S[/E1] genotype, with a wide range of neurological manifestations, including focal parieto-occipital lobe seizures, migraine headaches, [E2]cerebellar ataxia[/E2], sensory– motor axonal neuropathy, and impairment of visual perception and cognitive function",W748S,GENE_VARIANT,56,61,cerebellar ataxia,HPO_TERM,191,208,NoRelation,gold
polg_23430898_spans.jsonl::line1,"We present a case where an entire POLG1 allele is deleted, with a known pathogenic mutation (W748S) on the remaining allele","We present a case where an entire [E1]POLG1[/E1] allele is deleted, with a known pathogenic mutation (W748S) on the remaining allele[E2][/E2]",POLG1,GENE,630,635,slightly retarded motor development,HPO_TERM,811,846,NoRelation,gold
polg_19187065_spans.jsonl::line8,"However, we believe this to be the first report of LB pathology in a patient with Parkinsonism, PEO and multiple mtDNA deletions, secondary to a POLG1","However, we believe this to be the first report of LB pathology in a patient with Parkinsonism, [E2]PEO[/E2] and multiple mtDNA deletions, secondary to a [E1]POLG1[/E1]",POLG1,GENE,330,335,PEO,HPO_TERM,281,284,NoRelation,gold
polg_20803213_full.jsonl::line9,Urgent DNA analysis indeed revealed a homozygous (A467T) mutation of the POLG1-gene confirming the diagnosis of juvenileonset Alpers’ syndrome.,Urgent DNA analysis indeed revealed a homozygous (A467T) mutation of the POLG1-gene confirming the d[E2]iagnosis of juvenileonset Alpers’ syndrom[/E2][E1]POLG1[/E1]-gene confirming the diagnosis of juvenileonset Alpers’ syndrome.,POLG1,GENE,782,787,leftsided pulvinar thalamic abnormalities,HPO_TERM,666,707,NoRelation,gold
polg_25724872_spans.jsonl::line2,"Multiple deletions of mtDNA were detected, and sequencing of the POLG1 gene identiﬁed a novel substitution,","Multiple deletions of m[E2]tDNA were detect[/E2]ed, and sequencing of the [E1]POLG1[/E1] gene identiﬁed a novel substitution,",POLG1,GENE,825,830,ragged red ﬁbres,HPO_TERM,676,692,NoRelation,gold
polg_30936349_spans.jsonl::line2,Genetic studies showed a compound heterozygosity of known pathogenic mutations in the poLG1 gene (variant t252I/p587 L in cis configuration in allele 1 and variant r807C in allele 2),Genetic studies showed a compound heterozygosity of known pathogenic mutations in the poLG1 gene (variant t252I/p587 L in cis configura[E2]tion in allele [/E2][E1]p587 L[/E1] in cis configuration in allele 1 and variant r807C in allele 2),p587 L,GENE_VARIANT,159,165,ophthalmoplegia,HPO_TERM,0,15,NoRelation,gold
polg_20803213_full.jsonl::line14,"One week after admission, DNA analysis revealed a homozygous A467T mutation of the POLG1-gene, confirming the suspected diagnosis of juvenile-onset Alpers’ syndrome","One week after admission, DNA analysis revealed a homozygous A467T mutation of the POLG1-gene, confirming the suspected diagnosis of juvenile-[E2]onset Alpers’ syndro[/E2][E1]POLG1[/E1]-gene, confirming the suspected diagnosis of juvenile-onset Alpers’ syndrome",POLG1,GENE,695,700,mesial temporal lobe,HPO_TERM,590,610,NoRelation,gold
polg_21956653_spans.jsonl::line55,"Nuclear DNA genetic analysis revealed compound heterozygosity for POLG gene mutation, p.W748S, and pT914P variant","Nuclear DNA genetic analysis revealed compound heterozygosity for [E1]POLG[/E1] gene mutation, p.W748S, and pT914P variant[E2][/E2]",POLG,GENE,587,591,pancerebellar syndrome,HPO_TERM,739,761,NoRelation,gold
polg_25724872_spans.jsonl::line8,"Given this ﬁnding, the POLG1 gene was sequenced by the standard Sanger method","Giv[E2]en this ﬁnding, the POLG[/E2][E1]POLG1[/E1] gene was sequenced by the standard Sanger method",POLG1,GENE,1320,1325,multiple mtDNA deletions,HPO_TERM,1223,1247,NoRelation,gold
polg_18783964_spans.jsonl::line2,"This case concerns a 17-year-old boy, who was given the diagnosis of Alpers syndrome only postmortem when a homozygous 1399G!A (A467T) mutation was found in the linker-region of POLG1","This case concerns a 17-year-old boy, who was given the diagnosis of [E2]Alpers syndrome[/E2] only postmortem when a homozygous 1399G!A ([E1]A467T[/E1]) mutation was found in the linker-region of POLG1",A467T,GENE_VARIANT,128,133,Alpers syndrome,HPO_TERM,69,84,NoRelation,gold
polg_21956653_spans.jsonl::line55,"Nuclear DNA genetic analysis revealed compound heterozygosity for POLG gene mutation, p.W748S, and pT914P variant","Nuclear DNA genetic analysis revealed compound heterozygosity for POLG gene mutation, p.W748S, and [E1]pT914P[/E1] variant[E2][/E2]",pT914P,GENE_VARIANT,620,626,migraines,HPO_TERM,663,672,NoRelation,gold
polg_18502641_spans.jsonl::line376,The maternal allele predicts a p.W918R aminoacid sub- stitution in a highly conserved position in the pol cA poly- merase domain (http://dir-apps.niehs.nih.gov/polg/) [8],The maternal allele predicts a p.W918R aminoacid sub- stitution in a highly conserved position in the [E2]pol cA poly- merase domain (http://dir-apps.n[/E2][E1]p.W918R[/E1] aminoacid sub- stitution in a highly conserved position in the pol cA poly- merase domain (http://dir-apps.niehs.nih.gov/polg/) [8],p.W918R,GENE_VARIANT,131,138,levodopa-responsive pseudo-orthostatic tremor,HPO_TERM,32,77,NoRelation,gold
polg_25724872_spans.jsonl::line2,"Multiple deletions of mtDNA were detected, and sequencing of the POLG1 gene identiﬁed a novel substitution,","[E2]Multiple deletions of mtDNA[/E2] were detected, and sequencing of the [E1]POLG1[/E1] gene identiﬁed a novel substitution,",POLG1,GENE,825,830,Multiple deletions of mtDNA,HPO_TERM,760,787,NoRelation,gold
polg_21515089_spans.jsonl::line1,"We describe a 16-year-old woman with a rare POLG1 A467T/W748S genotype, with a wide range of neurological manifestations, including focal parieto-occipital lobe seizures, migraine headaches, cerebellar ataxia, sensory– motor axonal neuropathy, and impairment of visual perception and cognitive function","We describe a 16-year-old woman with a rare POLG1 A467T/[E1]W748S[/E1] genotype, with a wide range of neurological manifestations, including focal parieto-occipital lobe seizures, [E2]migraine headaches[/E2], cerebellar ataxia, sensory– motor axonal neuropathy, and impairment of visual perception and cognitive function",W748S,GENE_VARIANT,56,61,migraine headaches,HPO_TERM,171,189,NoRelation,gold
polg_19766516_full.jsonl::line2,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of p.A467T/p.G848S and with a lethal outcome,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of [E1]p.A467T[/E1]/p.G848S and with a lethal outcome[E2][/E2],p.A467T,GENE,78,85,IL-8,HPO_TERM,185,189,NoRelation,gold
polg_20803213_full.jsonl::line14,"One week after admission, DNA analysis revealed a homozygous A467T mutation of the POLG1-gene, confirming the suspected diagnosis of juvenile-onset Alpers’ syndrome","One week after admission, DNA analysis revealed a homozygous A467T mutation of the POLG1-gene, confirming the suspected diagnosis of juvenile-[E2]onset Alpers’ syndro[/E2][E1]A467T[/E1] mutation of the POLG1-gene, confirming the suspected diagnosis of juvenile-onset Alpers’ syndrome",A467T,GENE_VARIANT,673,678,mesial temporal lobe,HPO_TERM,590,610,NoRelation,gold
polg_30936349_spans.jsonl::line2,Genetic studies showed a compound heterozygosity of known pathogenic mutations in the poLG1 gene (variant t252I/p587 L in cis configuration in allele 1 and variant r807C in allele 2),Genetic studies showed a compound heterozygosity of known pathogenic mutations in the poLG1 gene (variant t252I/p587 L in cis configura[E2]tion in allele [/E2][E1]poLG1[/E1] gene (variant t252I/p587 L in cis configuration in allele 1 and variant r807C in allele 2),poLG1,GENE,133,138,ophthalmoplegia,HPO_TERM,0,15,NoRelation,gold
polg_22778364_spans.jsonl::line16,Our patient harboured two novel POLG1 mutations,Our patient harboured two novel [E1]POLG1[/E1] mutations[E2][/E2],POLG1,GENE,32,37,adult-onset,HPO_TERM,90,101,NoRelation,gold
polg_19766516_full.jsonl::line2,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of p.A467T/p.G848S and with a lethal outcome,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of p.A467T/[E1]p.G848S[/E1] and with a lethal outcome[E2][/E2],p.G848S,GENE,86,93,elevated,HPO_TERM,155,163,NoRelation,gold
polg_21515089_spans.jsonl::line1,Treatment of epilepsy in patients with a POLG1 compound heterozygous A467T/W748S genotype is very challenging,[E2]Treatment of [/E2]epilepsy in patients with a POLG1 compound heterozygous A467T/[E1]W748S[/E1] genotype is very challenging,W748S,GENE_VARIANT,379,384,cerebellar ataxia,HPO_TERM,191,208,NoRelation,gold
polg_18783964_spans.jsonl::line2,"This case concerns a 17-year-old boy, who was given the diagnosis of Alpers syndrome only postmortem when a homozygous 1399G!A (A467T) mutation was found in the linker-region of POLG1","This case concerns a 17-year-old boy, who was given the diagnosis of [E2]Alpers syndrome[/E2] only postmortem when a homozygous 1399G!A (A467T) mutation was found in the linker-region of [E1]POLG1[/E1]",POLG1,GENE,178,183,Alpers syndrome,HPO_TERM,69,84,NoRelation,gold
polg_22778364_spans.jsonl::line15,Molecular genetic analysis revealed multiple mtDNA deletions in muscle and heterozygous in trans mutations p.998S>L and p.1184D>H in the POLG1 gene,Molecular genetic analysis revealed [E2]multiple mtDNA deletions[/E2] in muscle and heterozygous in trans mutations [E1]p.998S>L[/E1] and p.1184D>H in the POLG1 gene,p.998S>L,GENE_VARIANT,355,363,multiple mtDNA deletions,HPO_TERM,284,308,NoRelation,gold
polg_25129007_spans.jsonl::line7,"The NGS followed by Sanger sequencing in the patient revealed a previously reported homozygous mutation, c.3286C>T (p.Arg1096Cys) in POLG gene, thus confirming diagnosis of POLG-related hepato-cerebral form of mtDNA depletion syndrome overlapping with AlpersHuttenlocher syndrome","The NGS followed by Sanger sequencing in the patient revealed a previously reported homozygous mutation[E1], c.3286C>T[/E1] (p.Arg1096Cys) in POLG gene, thus confirming diagnosis of POLG-related hepato-cerebral form of [E2]mtDNA depletion[/E2] syndrome overlapping with AlpersHuttenlocher syndrome",", c.3286C>T",GENE_VARIANT,239,250,mtDNA depletion,HPO_TERM,346,361,NoRelation,gold
polg_19998270_spans.jsonl::line5,"1B) and ruled out a depression-induced ‘‘pseudo-Parkinsonism.’’ In addition, transcranial sonography (performed by an examiner blind to the history and clinical examination of the patient) revealed a hyperechogenic substantia nigra and a hypoechogenic raphe (Fig 1D), thus resembling the characteristic sonography midbrain ﬁndings of IPD with depression.5 Because of the suggestive phenotype and family history, a genetic analysis of the POLG gene was initiated, revealing a heterozygous Tyr955Cys mutation, which is known to present, interalia, as POLG-P with autosomal dominant inheritance.1","1B) and ruled out a depression-induced ‘‘pseudo-Parkinsonism.’’ In addition, transcranial sonography (performed by an examiner blind to the history and clinical examination of the patient) revealed a hyperechogenic substantia nigra and a hypoechogenic raphe (Fig 1D), thus resembling the characteristic sonography midbrain ﬁndings of IPD with depression.5 Because of the suggestive phenotype and family history, a genetic analysis of the POLG gene was initiated, revealing a heterozygous Tyr955Cys mutati[E2]on, which is known to present, interalia, as POLG-P with a[/E2][E1]Tyr955Cys[/E1] mutation, which is known to present, interalia, as POLG-P with autosomal dominant inheritance.1",Tyr955Cys,GENE_VARIANT,619,628,symmetric reduction of nigrostriatal dopamine transporters,HPO_TERM,42,100,NoRelation,gold
polg_21515089_spans.jsonl::line1,Treatment of epilepsy in patients with a POLG1 compound heterozygous A467T/W748S genotype is very challenging,Treatment of epilepsy in patients with a POLG1 compou[E2]nd heterozygous A467T/W748S gen[/E2][E1]POLG1[/E1] compound heterozygous A467T/W748S genotype is very challenging,POLG1,GENE,345,350,impairment of visual perception,HPO_TERM,248,279,NoRelation,gold
polg_21956653_spans.jsonl::line55,"Nuclear DNA genetic analysis revealed compound heterozygosity for POLG gene mutation, p.W748S, and pT914P variant","Nuclear DNA genetic analysis revealed compound heterozygosity for POLG gene mutation, [E1]p.W748S[/E1], and pT914P variant[E2][/E2]",p.W748S,GENE_VARIANT,607,614,migraines,HPO_TERM,663,672,NoRelation,gold
polg_21515089_spans.jsonl::line1,"We describe a 16-year-old woman with a rare POLG1 A467T/W748S genotype, with a wide range of neurological manifestations, including focal parieto-occipital lobe seizures, migraine headaches, cerebellar ataxia, sensory– motor axonal neuropathy, and impairment of visual perception and cognitive function","We describe a 16-year-old woman with a rare [E1]POLG1[/E1] A467T/W748S genotype, with a wide range of neurological manifestations, including focal parieto-occipital lobe seizures, migraine headaches, [E2]cerebellar ataxia[/E2], sensory– motor axonal neuropathy, and impairment of visual perception and cognitive function",POLG1,GENE,44,49,cerebellar ataxia,HPO_TERM,191,208,NoRelation,gold
polg_21515089_spans.jsonl::line1,Treatment of epilepsy in patients with a POLG1 compound heterozygous A467T/W748S genotype is very challenging,Treatment of epilepsy in patients with a POLG1 compou[E2]nd heterozygous A467T/W748S gen[/E2][E1]A467T[/E1]/W748S genotype is very challenging,A467T,GENE_VARIANT,373,378,impairment of visual perception,HPO_TERM,248,279,NoRelation,gold
polg_23248042_spans.jsonl::line1,Mitochondrial disorder was clinically suspected and a homozygous c.2243G>C mutation (p.Trp748Ser) was discovered in the POLG1 gene,Mitochondrial[E2] disorder w[/E2]as clinically suspected and a [E1]homozygous c.2243G>C[/E1] mutation (p.Trp748Ser) was discovered in the POLG1 gene,homozygous c.2243G>C,GENE_VARIANT,751,771,Visual aura,HPO_TERM,580,591,NoRelation,gold
polg_20803213_full.jsonl::line9,"Since a POLG1 mutation syndrome was suspected, valproic acid was avoided","Since a [E1]POLG1[/E1] mutation syndrome was suspected, valproic acid was avoided[E2][/E2]",POLG1,GENE,218,223,right-sided hemiparesis,HPO_TERM,447,470,NoRelation,gold
polg_19187065_spans.jsonl::line8,"However, we believe this to be the first report of LB pathology in a patient with Parkinsonism, PEO and multiple mtDNA deletions, secondary to a POLG1","However, we believe this to be the first report of LB pathology in a patient with [E2]Parkinsonism[/E2], PEO and multiple mtDNA deletions, secondary to a [E1]POLG1[/E1]",POLG1,GENE,330,335,Parkinsonism,HPO_TERM,267,279,NoRelation,gold
polg_27422324_spans.jsonl::line6,AHS was suspected and mutation analysis of the polymerase gamma gene (POLG) revealed compound heterozygotes mutations A467T/W748S,AHS was susp[E2]ected and mutation analysis of[/E2] the polymerase gamma gene ([E1]POLG[/E1]) revealed compound heterozygotes mutations A467T/W748S,POLG,GENE,802,806,elevated lactate concentration,HPO_TERM,615,645,NoRelation,gold
polg_23248042_spans.jsonl::line1,Mitochondrial disorder was clinically suspected and a homozygous c.2243G>C mutation (p.Trp748Ser) was discovered in the POLG1 gene,Mitochondrial disorder was cl[E2]inicall[/E2]y suspected and a [E1]homozygous c.2243G>C[/E1] mutation (p.Trp748Ser) was discovered in the POLG1 gene,homozygous c.2243G>C,GENE_VARIANT,751,771,aphasia,HPO_TERM,596,603,NoRelation,gold
polg_20803213_spans.jsonl::line9,"Since a POLG1 mutation syndrome was suspected, valproic acid was avoided","Since a [E1]POLG1[/E1] mutation syndrome was suspected, valproic acid was avoided[E2][/E2]",POLG1,GENE,218,223,right-sided hemiparesis,HPO_TERM,447,470,NoRelation,gold
polg_21515089_spans.jsonl::line1,"We describe a 16-year-old woman with a rare POLG1 A467T/W748S genotype, with a wide range of neurological manifestations, including focal parieto-occipital lobe seizures, migraine headaches, cerebellar ataxia, sensory– motor axonal neuropathy, and impairment of visual perception and cognitive function","We describe a 16-year-old woman with a rare POLG1 [E1]A467T[/E1]/W748S genotype, with a wide range of neurological manifestations, including focal parieto-occipital lobe seizures, [E2]migraine headaches[/E2], cerebellar ataxia, sensory– motor axonal neuropathy, and impairment of visual perception and cognitive function",A467T,GENE_VARIANT,50,55,migraine headaches,HPO_TERM,171,189,NoRelation,gold
polg_20803213_spans.jsonl::line9,"Since a POLG1 mutation syndrome was suspected, valproic acid was avoided","[E2][/E2]Since a [E1]POLG1[/E1] mutation syndrome was suspected, valproic acid was avoided",POLG1,GENE,218,223,right-sided focal motor seizures,HPO_TERM,92,124,NoRelation,gold
polg_22342071_spans.jsonl::line4,[Gly848Ser]) were found in the POLG1 gene,[Gly848Ser]) were found in the [E1]POLG1[/E1] gene[E2][/E2],POLG1,GENE,760,765,refractory mixed type seizures,HPO_TERM,818,848,NoRelation,gold
polg_19766516_spans.jsonl::line2,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of p.A467T/p.G848S and with a lethal outcome,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of [E1]p.A467T[/E1]/p.G848S and with a lethal outcome[E2][/E2],p.A467T,GENE,78,85,IFN-c,HPO_TERM,191,196,NoRelation,gold
polg_23248042_spans.jsonl::line1,Mitochondrial disorder was clinically suspected and a homozygous c.2243G>C mutation (p.Trp748Ser) was discovered in the POLG1 gene,Mitochondrial disorder was cl[E2]inicall[/E2]y suspected and a homozygous c.2243G>C mutation ([E1]p.Trp748Ser[/E1]) was discovered in the POLG1 gene,p.Trp748Ser,GENE_VARIANT,782,793,aphasia,HPO_TERM,596,603,NoRelation,gold
polg_23248042_spans.jsonl::line3,"Here, we describe successful treatment of a 26-year-old woman with severe episodes of POLG-associated epilepsy (non-convulsive status epilepticus","Here, we describe successful treatment of a 26-year-old woman with severe episodes of [E1]POLG[/E1]-associated [E2]epilepsy[/E2] (non-convulsive status epilepticus",POLG,GENE,233,237,epilepsy,HPO_TERM,249,257,NoRelation,gold
polg_19766516_full.jsonl::line2,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of p.A467T/p.G848S and with a lethal outcome,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of p.A467T/[E1]p.G848S[/E1] and with a lethal outcome[E2][/E2],p.G848S,GENE,86,93,"CSF neopterin,",HPO_TERM,164,178,NoRelation,gold
polg_22778364_spans.jsonl::line16,Our patient harboured two novel POLG1 mutations,Our patient harboured two novel [E1]POLG1[/E1] mutations[E2][/E2],POLG1,GENE,32,37,encephalopathy,HPO_TERM,155,169,NoRelation,gold
polg_21515089_spans.jsonl::line4,"We describe here a patient with a rare POLG1 A467T/W748S compound heterozygous genotype with a wide range of neurological and nonneurological manifestations, including focal seizures, migraine ⁎ Corresponding author at: 900 Walnut Street, Suite 200, Philadelphia, PA 19107, USA","We describe here a patient with a rare [E1]POLG1[/E1] A467T/W748S compound heterozygous genotype with a wide range of neurological and nonneurological manifestations, including [E2]focal seizures[/E2], migraine ⁎ Corresponding author at: 900 Walnut Street, Suite 200, Philadelphia, PA 19107, USA",POLG1,GENE,39,44,focal seizures,HPO_TERM,168,182,NoRelation,gold
polg_19766516_spans.jsonl::line2,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of p.A467T/p.G848S and with a lethal outcome,We describe a 3.5-year-old female with [E2]Alpers disease[/E2] with a POLG genotype of p.A467T/[E1]p.G848S[/E1] and with a lethal outcome,p.G848S,GENE,86,93,Alpers disease,HPO_TERM,39,53,NoRelation,gold
polg_30936349_spans.jsonl::line2,Genetic studies showed a compound heterozygosity of known pathogenic mutations in the poLG1 gene (variant t252I/p587 L in cis configuration in allele 1 and variant r807C in allele 2),Genetic studies showed a compound heterozygosity of known pathogenic mutations in the poLG1 gene (variant t252I/p587 L in cis configura[E2]tion in allele [/E2][E1]t252I[/E1]/p587 L in cis configuration in allele 1 and variant r807C in allele 2),t252I,GENE_VARIANT,153,158,ophthalmoplegia,HPO_TERM,0,15,NoRelation,gold
polg_22342071_spans.jsonl::line4,[Gly848Ser]) were found in the POLG1 gene,[Gly848Ser]) were found in the [E1]POLG1[/E1] gene[E2][/E2],POLG1,GENE,760,765,psychomotor regression,HPO_TERM,881,903,NoRelation,gold
polg_22342071_spans.jsonl::line14,predicting p.Ala467Thr substitution (paternal) and c.2542G>A predicting p.Gly848Ser substitution (maternal).,predicting p.Ala467Thr substitution (paternal) and c.2542[E2]G>A predicting p.Gly848Ser substitution (maternal[/E2][E1]c.2542G>A[/E1] predicting p.Gly848Ser substitution (maternal).,c.2542G>A,GENE_VARIANT,258,267,signal intensity in the right inferior colliculus,HPO_TERM,156,205,NoRelation,gold
polg_19766516_full.jsonl::line2,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of p.A467T/p.G848S and with a lethal outcome,We describe a 3.5-year-old female with Alpers disease with a POLG genotype of [E1]p.A467T[/E1]/p.G848S and with a lethal outcome[E2][/E2],p.A467T,GENE,78,85,"CSF neopterin,",HPO_TERM,164,178,NoRelation,gold
polg_25286830_spans.jsonl::line2,"Because of suspected mitochondrial depletion disorder, testing was performed for mitochondrial abnormalities including analysis of the POLG gene, which revealed two pathogenic mutations, c.1399G>A (p.A467T) and c.3285C>G (p.S1095R)","Because of suspected mitochondrial depletion disorder, testing was performed for mitochondrial abnormalities including analysis of the POLG gene, which revealed two pathogenic mutations, c.1399G>A (p.A467T) and [E1]c.3285C>G[/E1] (p.S1095R)[E2][/E2]",c.3285C>G,GENE,1028,1037,mild atrophy,HPO_TERM,1254,1266,NoRelation,gold
polg_20803213_full.jsonl::line9,Urgent DNA analysis indeed revealed a homozygous (A467T) mutation of the POLG1-gene confirming the diagnosis of juvenileonset Alpers’ syndrome.,Urgent DNA analysis indeed revealed a homozygous (A467T) m[E2]utation of the POLG1-gene [/E2][E1]A467[/E1]T) mutation of the POLG1-gene confirming the diagnosis of juvenileonset Alpers’ syndrome.,A467,GENE_VARIANT,759,763,cortical occipital lesions,HPO_TERM,624,650,NoRelation,gold
